Back to list

InterWest Partners

InterWest invests an average of about $7 - 15 million over the span of their involvement with each company in their portfolio. They invest in companies through the full range of venture investment stages, and investments may be staged over several rounds of financing. Although they generally begin their involvement in the early stages of a company's development, they pursue attractive opportunities based on their individual merits rather than their investment stage.

Farah Champsi

Managing Partner

Keval Desai

General Partner

Doug Fisher

Executive in Residence

Flip Gianos

General Partner Emeritus

W. Stephen Holmes

General Partner Emeritus

GK

Gilbert Kliman

Managing Partner

Gil Kliman

Managing Partner

Khaled Nasr

General Partner and COO

Arnie Oronsky

Managing Partner

AL

Arnold L. Oronsky

Managing Partner

Michelle Snyder

Advisor

Karen Wilson

CFO

Reza Zadno

Advisor

425 past transactions

Staccato Communications

Series B in 2004
Staccato Communications, Inc. offers ultra wideband wireless enabled devices for the wireless USB, Bluetooth, and Internet protocol connectivity to the personal computing, consumer electronics, and mobile phone industries. Its products include single-chip integrated circuits, device adapter and device module design kits, reference design kits, wireless USB development kits, and streaming services development kits. The company also provides Ripcord Software, which provides a software stack for variety of ultra wide band applications, as well as includes installers, firmware, middleware, drivers, customization tools, and firmware upgrade tools. Staccato Communications’ products are used in various applications, such as printers, camera, mass storage devices, portable media players, wireless docking, wireless projectors, Web cameras, wireless HDTV, wireless speakers, set top boxes, wireless displays, purchasing content, sharing content, and personal servers. Staccato Communications, Inc. was formerly known as Discrete Time Communications, Inc. The company was founded in 2002 and is based in San Diego, California.

PMV Pharmaceutcals

Series A in 2014
PMV Pharma is developing first-in-class p53 and p53 pathway modulators for the treatment of cancer. Bringing together leaders in the field to utilize over three decades of p53 biology, PMV Pharma combines unique biological understanding with pharmaceutical development focus.
The mission of Integrated Diagnostics is to leverage powerful emerging technologies in the development of diagnostic products that enable physicians and patients to manage complex and important diseases such as cancer, diabetes and Alzheimer's through blood tests that can monitor tens to hundreds of disease markers simultaneously. The company plans to develop a pipeline of game-changing diagnostic products that enable the diagnosis and prognosis of a variety of diseases. The company is based on the concept of a systems view of disease where pathophysiology arises from disease-perturbed networks of proteins, genes and other molecules.

The RealReal, Inc.

Series D in 2015
The RealReal, Inc. operates an online marketplace for consigned luxury goods. It offers various resale product categories, including women’s, men’s, kids’, jewelry, and watches, as well as home and art products. The company was founded in 2011 and is headquartered in San Francisco, California.

Badgeville

Series C in 2012
Badgeville is the leading business gamification company with hundreds of global brand customers. With its unique combination of in-app gamification, SaaS platform and big data analytics, Badgeville is building the future of work. The company was founded in 2010 and is headquartered in Silicon Valley. Based in Redwood, CA, the Badgeville team includes experts from Zynga, Playdom, Omniture, Google, Salesforce.com, Amazon, WebEx, Microsoft and more. Badgeville investors are InterWest Partners, Norwest Venture Partners, Trinity Ventures and El Dorado Ventures. To learn more, follow @Badgeville or visit www.badgeville.com.

Tesaro, Inc.

Series B in 2011
Founded in 2010, TESARO is a privately held oncology-focused biopharmaceutical company dedicated to improving the lives of cancer patients. The Company intends to leverage the experience and competencies of its management team to identify, acquire and develop promising drug candidates; and to commercialize safer and more effective products for the treatment and support of cancer patients. TESARO is developing rolapitant, a potent, selective neurokinin-1 receptor antagonist that has completed Phase 2 clinical testing for the prevention of chemotherapy induced nausea and vomiting, and is advancing its ALK inhibitor program for oncology indications. Phase 3 clinical testing of rolapitant is planned to commence during 2011 and the first ALK inhibitor clinical trial is targeted to begin in 2012. TESARO was co-founded by former executives of MGI PHARMA, an oncology and acute-care focused biopharmaceutical company that Eisai Co., Ltd. acquired in 2008 for $3.9 billion. TESARO is headquartered in Waltham, Massachusetts.

Drais Pharmaceuticals

Series A in 2012
Drais Pharmaceuticals, Inc. is a venture capital supported drug development company with an exciting new business model. Through strong relationships with Astellas Pharma Inc. and our venture capital investors - InterWest Partners, Sutter Hill Ventures, and Astellas Venture Management LLC, we have created multiple virtual companies to enable the development of interesting novel compounds in a variety of therapeutic areas. Our focus is on early stage development through proof of concept. Our business model relies on a small internal team who provide drug development services to those virtual companies via vendors and CROs. Our internal experts are able to move compounds rapidly through key development milestones and decision points, thus de-risking programs early in development.

AccelChip

Series C in 2005
AccelChip, Inc. provides algorithmic synthesis solutions for digital signal processing (DSP) design. The company develops and markets design tools, integrated verification flows, and parametric intellectual property toolkits that automate the development and implementation of DSP algorithms in field programmable gate-arrays and application-specific integrated circuits. AccelChip, Inc. was formerly known as Mach Design Systems, Inc.

Participate Systems

Series D in 2002
Participate Systems provides outsourced online sales and customer support community solutions. The platform offers self-help solutions, software and management services, monthly and quarterly reports, and operating plans.

Scale Eight

Series D in 2002
Scale Eight is an internet company. It offers virtually limitless storage capacity, allowing companies to grow their online offerings. Scale Eight delivers file storage solutions technology through its global storage service and in a family of network-attached storage products. Scale Eight was founded by Josh Coates and is located in San Francisco, California.

Epocrates

Series C in 2002
Epocrates develops mobile and online clinical information and decision support software that enables health-care professionals to find answers more quickly and confidently at the point of care. 1 out of 3 U.S. physicians and 1 out of 3 U.S. medical students currently use Epocrates software.
PrimeraDx, Inc. offers multiplexed infectious disease assays. It provides Scalable Target Amplification Routine technology, which is a method for simultaneous quantitative measurement of multiple target nucleic acids. The company also offers ViraQuant, a multiplexed assay providing quantitative and simultaneous measurement of viruses; and FungiQuant Yeast and FungiQuant Mold, which are fungal panels for mycology testing. Its products are used in miRNA, DNA methylation, quantitative genotyping, gene expression, and viral load measurement applications. PrimeraDx, Inc. was founded in 2004 and is based in Mansfield, Massachusetts.

Gobiquity, Inc.

Venture Round in 2021
Gobiquity, Inc. provides prescribed mobile health applications for the early detection and prevention of health disorders and chronic diseases. It offers GoCheck Kids, a smartphone app that detects amblyopia risk factors and meets the American Association for Pediatric Ophthalmology and Strabismus guidelines for vision screening in children. Gobiquity, Inc. was formerly known as ICHECK Health Connection, Inc. The company was founded in 2010 and is based in Aliso Viejo, California.

Bivio Networks

Venture Round in 2008
Founded in 2000, Bivio Networks is dedicated to providing leading networking products that enable government agencies and service providers to control, monitor, and secure critical network infrastructure. A leader in cyber intelligence, cyber security and network control solutions, Bivio has deployed its products in a wide range of solutions. Bivio’s global customer base includes leading intelligence agencies, military organizations and service providers. Bivio is privately-held and is headquartered in the San Francisco Bay Area with office locations worldwide. Specialties Cyber Security, Cyber Intelligence, Deep Packet Inspection (DPI) Networking Systems, Mass Metadata Extraction and Analysis, Data Retention System, Cyber Investigation, network probe

Virsto Software

Series B in 2011
Virsto was founded in late 2007 by a team of storage and virtualization experts who saw that the old ways of doing storage were not working in the virtual server era. We believe we are building a visionary storage software platform that will fundamentally transform the data center – decoupling storage from the physical world once and for all to save organizations time and money. Virsto's solutions address the growing need for cost-effective and efficient storage for virtual servers and desktops. Companies around the world use Virsto to achieve increases in performance, reduce storage capital and operating costs, and streamline provisioning and data management for virtual computing.

Right90

Series C in 2008
Right90 is a sales and revenue forecasting software, designed to increase accountability in a company's sales department by actively compiling and analyzing data from different departments within the sales and management branches. Right90, Inc. was founded in 2003 and is headquartered in Foster City, California.

Damballa

Series E in 2014
As the experts in advanced threat protection, Damballa discovers active threats that bypass all security prevention layers. Damballa automatically identifies successful infections and pinpoints devices that represent the highest risk to a business. Our patent-pending solutions combine principles of data science and machine learning to discover threats without prior knowledge of them and regardless of device type, OS and threat vector. Damballa protects nearly a billion endpoints globally at enterprises in every major market and for the world’s largest ISP and telecommunications providers. For more information, visit www.damballa.com, or follow us on Twitter @DamballaInc. Watch an analyst interview with Brian Foster, CTO until June, 2015 , here: https://vimeo.com/129326008

Labrys Biologics

Series A in 2013
Labrys Biologics Inc., a company focused on treatments for chronic migraine. Labrys Biologics has acquired worldwide rights to RN-307 from Pfizer Inc. RN-307 is an antibody for the treatment of chronic migraine.

GAIN Fitness

Seed Round in 2011
GAIN Fitness's web and mobile applications generate personalized training plans based on exercise science, matched to an individual's body, goals, and lifestyle factors, to help regular exercisers optimize fitness and adapt to schedule changes. They motivate exercisers with social tie-ins and game mechanics, and keep things fresh with their custom built database of over 750 exercises. They're partnering with personal trainers and equipment retailers to sell interactive multimedia packs, a la App Store for Fitness.
InVisage Technologies Inc., a fabless semiconductor company, produces quantum dot-based image sensors. The company's product enables the high resolution images from handheld devices, such as camera phones and PDAs. Its products are used in security and surveillance, automotive imaging, military, and medical imaging applications, as well as mobile phone cameras, Webcams, and digital still cameras. The company was incorporated in 2005 and is based in Menlo Park, California.

Broadband Gateways

Venture Round in 2000
Broadband Gateways, developer of an intelligent premises gateway for the broadband voice and data market.

Flurry, Inc.

Series D in 2013
Flurry is an application that provides analytics for businesses to monitor the trends and habits of mobile users across multiple mobile applications. Flurry’s mobile analytics solution enables businesses to understand how consumers interact with their mobile applications. Over 125,000 companies use Flurry’s analytics platform in more than 400,000 applications to measure audience reach, engagement, retention, conversions, revenue, and more. The service is completely free, takes just five minutes for basic integration, and is continuously updated with the industry's advanced features. Flurry Analytics is available for iOS, Android, Windows Phone, HTML5, hybrid apps, mobile/web, Blackberry, and JavaME.

Carwoo

Series A in 2010
Carwoo is an online platform that enables its users to anonymously buy cars from dealers in their local area. Carwoo was launched in 2008 and is based in California.

Gynesonics

Series D in 2013
Gynesonics, Inc. designs and develops minimally invasive solutions for symptomatic uterine fibroids in women. The company offers Sonography-Guided Transcervical Fibroid Ablation (Sonata) System(The Sonata System) for the transcervical treatment of symptomatic uterine fibroids under intrauterine sonography guidance serving customers in the European Union. Gynesonics, Inc. was founded in 2005 and is based in Redwood City, California with an additional location in Beuningen, the Netherlands.

Marketo

Series D in 2010
Marketing automation software

MacroGenics

Venture Round in 2002
MacroGenics, Inc., a biotechnology company, focuses on the development, manufacture, and commercialization of immunotherapeutics for autoimmune disorders, cancer, and infectious diseases. The company is developing immune-based products, including monoclonal antibodies; and vaccines to prevent infections in healthy individuals. The company's Fc engineering technology enables to improve antibody functions to eliminate cancer cells. It is also developing products around the Dual Activating ReTargeting technology. The company was founded in 2000 and is headquartered in Rockville, Maryland.

Flurry, Inc.

Series D in 2012
Flurry is an application that provides analytics for businesses to monitor the trends and habits of mobile users across multiple mobile applications. Flurry’s mobile analytics solution enables businesses to understand how consumers interact with their mobile applications. Over 125,000 companies use Flurry’s analytics platform in more than 400,000 applications to measure audience reach, engagement, retention, conversions, revenue, and more. The service is completely free, takes just five minutes for basic integration, and is continuously updated with the industry's advanced features. Flurry Analytics is available for iOS, Android, Windows Phone, HTML5, hybrid apps, mobile/web, Blackberry, and JavaME.

NeuroPace

Venture Round in 2011
NeuroPace, Inc. designs, develops, manufactures, and markets implantable devices for the treatment of neurological disorders with responsive stimulation. It offers RNS System, a medical device that monitors and responds to brain activity. The company’s RNS System consists of a small implantable neuro stimulator that is connected to leads that are placed in up to two seizure onset areas. NeuroPace, Inc. was founded in 1997 and is based in Mountain View, California.
InVisage Technologies Inc., a fabless semiconductor company, produces quantum dot-based image sensors. The company's product enables the high resolution images from handheld devices, such as camera phones and PDAs. Its products are used in security and surveillance, automotive imaging, military, and medical imaging applications, as well as mobile phone cameras, Webcams, and digital still cameras. The company was incorporated in 2005 and is based in Menlo Park, California.

Apteligent

Series C in 2014
Crittercism, based in San Francisco, California, is the company behind the world’s first mobile application performance management (mAPM) solution. The company’s flagship product monitors every aspect of mobile app performance, allowing Developers, IT Operations and Product Managers to deliver high performing, highly reliable, highly resourceful mobile apps. Crittercism provides a real-time global view of app diagnostics across iOS, Android, Windows Phone 8, Hybrid and HTML5 apps and is used on more than 600 million unique devices and in more than 100 billion app sessions. The company’s investors include Google Ventures, Opus Capital and Shasta Ventures. Crittercism was part of **[AngelPad](http://angelpad.org) #2** in 2011

Restoration Robotics

Venture Round in 2016
Restoration Robotics is a privately held medical device company, is dedicated to revolutionizing the field of hair transplantation by developing and commercializing a state-of-the-art image-guided system (ARTAS™ System) that enables follicular unit extraction.

Nereus Pharmaceuticals

Series D in 2005
Nereus Pharmaceuticals, Inc. engages in the discovery and development of therapeutics for the treatment of oncology, infectious diseases, and inflammation. The company uses its marine microbiology technologies for the discovery and development of drug candidates. Its oncology drug candidates include NPI-2358, a tumor vascular disrupting agent for the treatment of solid tumors; and NPI-0052, a proteasome inhibitor for the treatment of solid tumors, lymphomas, and multiple myeloma. The company was founded in 1998 and is based in San Diego, California.

Brecis Communications

Series C in 2003
BRECIS Communications, a communications company focused on leading-edge, broadband multi-service network processor architectures.

Microfabrica Inc.

Series B in 2008
Microfabrica Inc. designs and develops micro-scale additive manufacturing solutions. The company offers a process that combines 3D printing that enables structures to be built layer by layer. Its process creates objects from layers of metal to produce extremely refined structures. The company also provides minuscule surgical instruments, including biopsy forceps and a tissue scaffold with linkages that allow it to expand with cell growth. It serves to aerospace, electronics, medical devices, and other industries. Microfabrica Inc. was formerly known as MEMGen Corporation and changed its name to Microfabrica Inc. in September 2003. The company was founded in 1999 and is headquartered in Van Nuys, California with an additional office in Santa Clara, California. As of May 20, 2019, Microfabrica Inc. operates as a subsidiary of Technoprobe S.p.A.

Welltok

Series B in 2013
Welltok is a data-driven, enterprise SaaS company that delivers the healthcare industry’s leading consumer activation platform. Welltok’s solutions empower health plans, employers, providers, and public entities to connect consumers with personalized health improvement resources, making it easy and rewarding for consumers to complete actions that optimize their health and wellbeing. The company was founded in 2009 and headquartered in Denver, Colorado.

APT Pharmaceuticals

Series B in 2008
APT Pharmaceuticals is a drug development company focused on repurposing well-characterized drugs for under-served populations. APT’s initial focus is on the pulmonary delivery of treatments for serious lung diseases.

Welltok

Series D in 2015
Welltok is a data-driven, enterprise SaaS company that delivers the healthcare industry’s leading consumer activation platform. Welltok’s solutions empower health plans, employers, providers, and public entities to connect consumers with personalized health improvement resources, making it easy and rewarding for consumers to complete actions that optimize their health and wellbeing. The company was founded in 2009 and headquartered in Denver, Colorado.

Pivot3

Series E in 2014
Global Hyper-Converged Infrastructure

C9 Inc.

Series B in 2009
C9 delivers predictive sales and marketing applications that increase revenue, generate more precise forecasts and mitigate pipeline risk. By combining data science with products that improve sales and marketing execution, C9 enables leading companies like Yahoo!, Pitney Bowes and Google to drive predictable growth. C9 is located in San Mateo and is backed by the Mayfield Fund, InterWest Partners and Leapfrog Ventures.

Get Satisfaction, Inc.

Series B in 2011
Based in San Francisco, Get Satisfaction provides an online community platform connecting companies with customers to foster relationships that unlock new value for both sides. Companies of all sizes and industries—from Kellogg's and P&G to [Sonos](/organization/sonos), [HootSuite](/organization/hootsuite) and [SugarCRM](/organization/sugarcrm)—rely on Get Satisfaction to deliver online communities that modernize customer support, accelerate sales, differentiate their brand and inspire new innovations. Get Satisfaction's community platform offers the fastest time to value for companies ready to embrace the way today’s customers want to engage.

Brand.net

Series B in 2008
Brand.net is an online advertising network focused exclusively on brand advertising. Their technology is designed to allow Brand advertisers and agencies to reach the right target in the right context, efficiently and measurably.

Spredfast

Series D in 2014
Spredfast, Inc. provides a social relationship platform that allows enterprise brands and organizations to manage, monitor, and measure their social media programs in the United States and internationally. The company was formerly known as Social Agency, Inc. and changed its name to Spredfast, Inc. in January 2010. Spredfast, Inc. was founded in 2008 and is based in Austin, Texas with an additional office in London, United Kingdom. As of October 2, 2018, Spredfast, Inc. operates as a subsidiary of Lithium Technologies Inc.

Damballa

Series D in 2011
As the experts in advanced threat protection, Damballa discovers active threats that bypass all security prevention layers. Damballa automatically identifies successful infections and pinpoints devices that represent the highest risk to a business. Our patent-pending solutions combine principles of data science and machine learning to discover threats without prior knowledge of them and regardless of device type, OS and threat vector. Damballa protects nearly a billion endpoints globally at enterprises in every major market and for the world’s largest ISP and telecommunications providers. For more information, visit www.damballa.com, or follow us on Twitter @DamballaInc. Watch an analyst interview with Brian Foster, CTO until June, 2015 , here: https://vimeo.com/129326008

Achates Power, Inc.

Series A in 2009
Achates Power specializes in the fields of combustion engine development, clean diesel, and 2-stroke oil control management. The company is on a mission to build better, more efficient engines, the company has an experienced staff of engineers and scientists focused on applying their proven technical know-how and expertise, coupled with the industry's leading-edge testing, simulation, and analysis tools. it was founded in 2004 and headquartered in San Diego, California.

Totango Ltd.

Series D in 2018
Totango, Inc. develops an enterprise grade customer success platform that allows users to connect their customers’ data, monitor health changes, and engage their customers. The company offers Customer Success Centre, a solution for customer engagement; Zoe, a solution for enterprise impact; and DNA-CX, a solution for multidimensional customer context in real-time. Its solutions include voice of the customer, customer onboarding, customer adoption, customer renewal, and customer escalation. The company was founded in 2010 and is based in Redwood City, California. Totango, Inc. operates as a subsidiary of Totango Ltd.

Spredfast

Series F in 2016
Spredfast, Inc. provides a social relationship platform that allows enterprise brands and organizations to manage, monitor, and measure their social media programs in the United States and internationally. The company was formerly known as Social Agency, Inc. and changed its name to Spredfast, Inc. in January 2010. Spredfast, Inc. was founded in 2008 and is based in Austin, Texas with an additional office in London, United Kingdom. As of October 2, 2018, Spredfast, Inc. operates as a subsidiary of Lithium Technologies Inc.

Pelican Imaging

Series C in 2013
Pelican Imaging Corporation is a venture-backed software start-up in the business of commercializing computational cameras for the smartphone market. The company is developing a new camera technology that directly addresses the challenges posed by conventional camera design and small pixels. Investors include Globespan Capital Partners, Granite Ventures, InterWest Partners, and IQT.
Centrexion Therapeutics is focused on developing new therapies for moderate to severe chronic pain that address the safety and efficacy gaps in the current treatment paradigm.We aim to relieve the suffering associated with chronic pain by creating treatments that address the safety and efficacy gaps in the current treatment paradigm.

Wiser Solutions

Series A in 2015
Wiser is the leading provider of actionable data for better decisions. Wiser collects and analyzes online and in-store data with unmatched speed, scale and accuracy. The Wiser platform then blends these insights with advanced workflow software to drive business value for brands and retailers. Using a unique combination of data science and human validation, Wiser offers integrated solutions for every aspect of retail, all in one place.

Nuventix

Venture Round in 2011
Nuventix is an active thermal management solutions company located in Austin, Texas. The Nuventix-developed SynJet® module is a newly patented synthetic jet cooling technology that utilizes turbulent pulses of air generated from an electromagnetic actuator. Based on early success with computer cooling, Nuventix's innovative approach to LED cooling is propelling that market forward two years ahead of analyst estimates - truly affecting the industry and allowing general illumination designs to harvest the efficiencies of the LED.

NewsCred

Series D in 2015
NewsCred, the global leader in enterprise content marketing, empowers the world’s most ambitious brands with powerful technology, the largest and most diverse content offerings, and proven, unrivaled expertise. Through its complete solution, NewsCred offers a repeatable methodology that guarantees ROI for the world’s leading CMOs and marketing leaders from companies including Barclays, Cox Communications, Fidelity, HPE, USAA, Virgin Media, and more. Founded in 2008, NewsCred serves hundreds of customers in over 70 countries from seven global offices. Learn more at NewsCred.com, join our community at NewsCred Insights and follow us on Twitter and LinkedIn.
Advanced Micro-Fabrication Equipment Inc. (中微半导体设备(上海)有限公司) is a Chinese global microfabrication equipment company serving customers in the semiconductor industry and relevant high-tech sectors. The company is a specialized supplier of key equipment for the production and development of micron-sized and nanoscale VLSI for the semiconductor industry in China and Asia. The company is focused on chemical vapor deposition and plasma etching products.

AppMesh

Seed Round in 2012
AppMesh is building the next generation business platform for mobile devices. Founded by salesforce.com veterans, we believe that in the post-PC era business applications need to be personal, seamless, and intuitive.

Tasman Networks

Venture Round in 1999
Tasman Networks is a manufacturer of Multi-service edge router.

MacroGenics

Series A in 2001
MacroGenics, Inc., a biotechnology company, focuses on the development, manufacture, and commercialization of immunotherapeutics for autoimmune disorders, cancer, and infectious diseases. The company is developing immune-based products, including monoclonal antibodies; and vaccines to prevent infections in healthy individuals. The company's Fc engineering technology enables to improve antibody functions to eliminate cancer cells. It is also developing products around the Dual Activating ReTargeting technology. The company was founded in 2000 and is headquartered in Rockville, Maryland.

Aria Systems, Inc.

Private Equity Round in 2018
Proven by the world's most demanding enterprises, including AAA NCNU, Constant Contact, Falck, Hootsuite, Pitney Bowes, Audi, Adobe, Telekom Denmark, Philips, Roku, and VMware, Aria helps enterprises grow their recurring revenue businesses. Aria helps clients take advantage of each customer-driven event − known as revenue moments − with agile billing, active customer engagement, and the rapid development of new products and services. With Aria's end-to-end active monetization platform, global brands can get to market faster with a wider variety of products and services, while maximizing customer satisfaction, retention, and lifetime value.

SignalDemand

Venture Round in 2008
SignalDemand delivers margin optimization software that enables process manufacturers to maximize profitability, even as costs and markets change around them. The company's applications rely on the latest econometric models, optimization algorithms and activity-based costing techniques.

LongBoard

Series C in 2002
LongBoard, Inc. provides software solutions to enable the telecommunications carriers and service providers to deliver converged multimedia services. Its products include MediaRoam that provides telecommunications carriers with the ability to deliver differentiated Initiation Protocol Multimedia Subsystem enabled multimedia services across fixed and mobile networks; LongBoard Multimedia Application Platform, which provides a carrier-class software infrastructure for integrating IP-based communications; and OnePhone, a personal mobility application that automatically and transparently switches calls between cellular and WiFi networks. LongBoard, Inc. was formerly known as Persona Software, Inc. and it changed its name to LongBoard, Inc. in February 2006. The company was founded in 1999 and is based in Santa Clara, California with sales offices in London, the United Kingdom and Tokyo, Japan.

Neuronetics

Series G in 2017
Neuronetics is focused on developing non-invasive therapies for psychiatric and neurological disorders using MRI-strength magnetic field pulses. They are the first and only company to have a non-systemic and non-invasive depression treatment cleared by the FDA for patients who have not benefited from prior antidepressant treatment. The company was founded in 2003 and is based in Malvern, Pennsylvania.

Staccato Communications

Venture Round in 2008
Staccato Communications, Inc. offers ultra wideband wireless enabled devices for the wireless USB, Bluetooth, and Internet protocol connectivity to the personal computing, consumer electronics, and mobile phone industries. Its products include single-chip integrated circuits, device adapter and device module design kits, reference design kits, wireless USB development kits, and streaming services development kits. The company also provides Ripcord Software, which provides a software stack for variety of ultra wide band applications, as well as includes installers, firmware, middleware, drivers, customization tools, and firmware upgrade tools. Staccato Communications’ products are used in various applications, such as printers, camera, mass storage devices, portable media players, wireless docking, wireless projectors, Web cameras, wireless HDTV, wireless speakers, set top boxes, wireless displays, purchasing content, sharing content, and personal servers. Staccato Communications, Inc. was formerly known as Discrete Time Communications, Inc. The company was founded in 2002 and is based in San Diego, California.

CardioMind

Series B in 2004
CardioMind, Inc. Inc manufactures therapeutic devices for cardiovascular diseases. The company also offers stent delivery systems, which are designed for use in lesion applications, as well as for the treatment of coronary and peripheral artery diseases. In addition, it provides invasive endovascular medical devices for treating neurological and cardiovascular diseases. The company was founded in 2003 and is based in Sunnyvale, California.

Gear6

Series C in 2006
Gear6 sells Memcached solutions enabling high-growth web sites to deliver and scale dynamic applications and content. By focusing on the emerging need for a dedicated web caching tier, Gear6 solutions improve the scalability of web applications and databases, improving quality of service and reducing infrastructure cost.

Epocrates

Series B in 2000
Epocrates develops mobile and online clinical information and decision support software that enables health-care professionals to find answers more quickly and confidently at the point of care. 1 out of 3 U.S. physicians and 1 out of 3 U.S. medical students currently use Epocrates software.

C9 Inc.

Series D in 2013
C9 delivers predictive sales and marketing applications that increase revenue, generate more precise forecasts and mitigate pipeline risk. By combining data science with products that improve sales and marketing execution, C9 enables leading companies like Yahoo!, Pitney Bowes and Google to drive predictable growth. C9 is located in San Mateo and is backed by the Mayfield Fund, InterWest Partners and Leapfrog Ventures.
Advanced Micro-Fabrication Equipment Inc. (中微半导体设备(上海)有限公司) is a Chinese global microfabrication equipment company serving customers in the semiconductor industry and relevant high-tech sectors. The company is a specialized supplier of key equipment for the production and development of micron-sized and nanoscale VLSI for the semiconductor industry in China and Asia. The company is focused on chemical vapor deposition and plasma etching products.

Diatos

Series D in 2007
Diatos is a biopharmaceutical company founded in 1999 and headquartered in Paris, France with two subsidiaries in Leuven, Belgium and in the San Francisco Bay Area, USA. Diatos is focused on the research, development and marketing of new versions of existing anti-cancer chemotherapeutic drugs with enhanced tumor targeting or improved biodistribution. Diatos has built its portfolio of drugs and drug candidates through a strategy of license acquisitions as well as an internal research and development activity based on its prodrug technologies, Vectocell® and Tumor-Selective Prodrug (TSP).

SpectraLinear

Series B in 2006
SpectraLinear, Inc., a fabless mixed signal IC company, designs, develops, manufactures, and markets timing circuits. The company's products include computer clocks, buffers, zero delay buffers, EMI reduction circuits, and systems clocks for the consumer and PC clock applications. Its products enable various electronic applications, such as digital television, high definition digital television, digital still camera, digital movie camera or camcorders, set-top box, multi function printers, laser and inkjet printers, copiers, notebook and desktop computers, servers, and communication systems, as well as automotive, gaming, cash registers, and other industrial applications. The company serves consumer, computer, and communication markets. It has locations in Istanbul, Turkey; Bangalore, India; Taiwan; and Japan. SpectraLinear, Inc. was founded in 2006 and is based in Santa Clara, California.

Satori Pharmaceuticals

Series B in 2011
Satori Pharmaceuticals is a neuroscience company focused on the discovery and development of disease-modifying therapies for Alzheimer's disease, Parkinson's disease and other neurodegenerative disorders.

CubeTree

Series B in 2009
CubeTree offers a full-featured enterprise collaboration suite built on an enterprise social networking platform. Companies can create private, secure enterprise social networks using CubeTree. By leveraging features which people already use in the consumer world – like user profiles, micro-blogging, follow/following news feeds and groups at CubeTree makes it easier for employees to understand and fully utilize the system. A full suite of collaboration tools is tightly integrated with CubeTree’s enterprise social networking platform, and includes wikis, blogs, polls, file sharing, link sharing, search and more. CubeTree has pre-built integrations to many consumer and enterprise products including Twitter®, Google Docs and Google Reader, Salesforce.com, WebEx and Basecamp. The standard version is free for unlimited users, allowing anyone to create a network for their company and invite colleagues to join. Premium versions offer additional features and storage.

Wiser Solutions

Venture Round in 2016
Wiser is the leading provider of actionable data for better decisions. Wiser collects and analyzes online and in-store data with unmatched speed, scale and accuracy. The Wiser platform then blends these insights with advanced workflow software to drive business value for brands and retailers. Using a unique combination of data science and human validation, Wiser offers integrated solutions for every aspect of retail, all in one place.

Brand.net

Series A in 2007
Brand.net is an online advertising network focused exclusively on brand advertising. Their technology is designed to allow Brand advertisers and agencies to reach the right target in the right context, efficiently and measurably.

SpectraLinear

Series A in 2006
SpectraLinear, Inc., a fabless mixed signal IC company, designs, develops, manufactures, and markets timing circuits. The company's products include computer clocks, buffers, zero delay buffers, EMI reduction circuits, and systems clocks for the consumer and PC clock applications. Its products enable various electronic applications, such as digital television, high definition digital television, digital still camera, digital movie camera or camcorders, set-top box, multi function printers, laser and inkjet printers, copiers, notebook and desktop computers, servers, and communication systems, as well as automotive, gaming, cash registers, and other industrial applications. The company serves consumer, computer, and communication markets. It has locations in Istanbul, Turkey; Bangalore, India; Taiwan; and Japan. SpectraLinear, Inc. was founded in 2006 and is based in Santa Clara, California.

Ribbon Payments, Inc.

Pre Seed Round in 2011
Ribbon Payments, Inc. operates a platform that allows users to sell and purchase products by sharing a unique showcase link. The company supports various types of products from physical and digital goods to services, such as T-shirts, mp3s, and tutoring products. It process debit and credit cards for payments. Ribbon Payments, Inc. was formerly known as Kout Inc. and changed its name to Ribbon Payments, Inc. in November 2012. The company was incorporated in 2011 and is based in San Francisco, California.

Trius Therapeutics

Series A in 2007
Trius Therapeutics is a biopharmaceutical company focused on the discovery, development and commercialization of innovative antibiotics for life-threatening infections. We have successfully completed two Phase 3 clinical trials for Tedizolid Phosphate (TR-701), formerly torezolid phosphate, in ABSSSI. Tedizolid is an IV and orally administered second generation oxazolidinone, for the treatment of serious gram-positive bacterial infections, including those caused by methicillin-resistant Staphylococcus aureus (MRSA). With the continuous increase in bacterial resistance to currently marketed drugs, serious infections are becoming more difficult, if not impossible to treat, and this has led to a clear need for novel therapeutics to treat multi-drug resistant bacterial infections. Trius is headquartered in San Diego, California. We have built a strong management team with significant development and regulatory experience. Our senior management team consists of nine individuals who collectively have been involved in the development and approval of a significant number of anti-infective drugs.
INVIDI Technologies Corporation provides software applications that track targeted advertising. It offers Advatar, a digital set-top box application that delivers addressable targeted advertising and marketing messages to individual viewers. It facilitates the sales of digital products, digital tiers, and digital services, such as VOD, PVR, and pay-per-view events; Internet, voice, and wireless services; and triple play offers. Advatar serves multi-channel video programming distributors, marketers, advertisers, and media buyers and sellers. The company also provides INVIDI Advertising Decision System, an addressable television advertising technology for managing advertising decisions and selections for household delivery in the evolving business of television advertising. INVIDI Technologies Corporation was founded in 2000 and is headquartered in Princeton, New Jersey.

Neuronetics

Series B in 2005
Neuronetics is focused on developing non-invasive therapies for psychiatric and neurological disorders using MRI-strength magnetic field pulses. They are the first and only company to have a non-systemic and non-invasive depression treatment cleared by the FDA for patients who have not benefited from prior antidepressant treatment. The company was founded in 2003 and is based in Malvern, Pennsylvania.

Cuyana

Venture Round in 2015
Cuyana is an online fashion brand that believes in fewer, better things. It creates apparel and accessories, designed with a classic, modern aesthetic, sourced from the world's highest quality materials and crafted to last a lifetime. By selling directly to customers rather than through other retailers, Cuyana is able to offer high-quality, timeless pieces at attainable prices. Cyana was founded in 2013 and is based in San Francisco, California.

MacroGenics

Series B in 2004
MacroGenics, Inc., a biotechnology company, focuses on the development, manufacture, and commercialization of immunotherapeutics for autoimmune disorders, cancer, and infectious diseases. The company is developing immune-based products, including monoclonal antibodies; and vaccines to prevent infections in healthy individuals. The company's Fc engineering technology enables to improve antibody functions to eliminate cancer cells. It is also developing products around the Dual Activating ReTargeting technology. The company was founded in 2000 and is headquartered in Rockville, Maryland.

BioMimetic Therapeutics

Series C in 2004
BioMimetic Therapeutics is a biotechnology company that develops products to help stimulate the body natural tissue regenerative process. The company's products and product candidates include Augment Injectable and Augment Rotator Cuff for several orthopedic and sports medicine indications comprising the treatment of foot and ankle fusions, the stimulation of wrist fracture healing, and the surgical treatment of rotator cuff tears, as well as Augment Tendinopathy Injection for injuries cause of tendon overuse. BioMimetic Therapeutics was founded on 1999 and is headquartered in Franklin, Tennessee.

Neuronetics

Series A in 2003
Neuronetics is focused on developing non-invasive therapies for psychiatric and neurological disorders using MRI-strength magnetic field pulses. They are the first and only company to have a non-systemic and non-invasive depression treatment cleared by the FDA for patients who have not benefited from prior antidepressant treatment. The company was founded in 2003 and is based in Malvern, Pennsylvania.

Celladon

Post in 2015
Celladon Corporation, a biotechnology company, develops and manufactures molecular therapies for the treatment of heart failure. Its products include SERCA2a, an enzyme that regulates calcium cycling and contractility in heart muscle cells; and MYDICAR, an enzyme replacement therapy for heart failure. Celladon was founded in 2000 and is based in La Jolla, California.
INVIDI Technologies Corporation provides software applications that track targeted advertising. It offers Advatar, a digital set-top box application that delivers addressable targeted advertising and marketing messages to individual viewers. It facilitates the sales of digital products, digital tiers, and digital services, such as VOD, PVR, and pay-per-view events; Internet, voice, and wireless services; and triple play offers. Advatar serves multi-channel video programming distributors, marketers, advertisers, and media buyers and sellers. The company also provides INVIDI Advertising Decision System, an addressable television advertising technology for managing advertising decisions and selections for household delivery in the evolving business of television advertising. INVIDI Technologies Corporation was founded in 2000 and is headquartered in Princeton, New Jersey.
QuatRx Pharmaceuticals Company, a biopharmaceutical company, engages in discovering, licensing, developing, and commercializing compounds in the areas of endocrine, metabolic, and cardiovascular therapeutics. Its products include Osphena for the treatment for vaginal atrophy, a common problem associated with estrogen deficiency in post-menopausal women. QuatRx Pharmaceuticals Company was founded in 2000 and is based in Ann Arbor, Michigan.

Platform Solutions

Series B in 2004
Platform Solutions, Inc. develops Open Mainframe computers compatible with a set of datacenter environments and operating systems. It offers Open Mainframe servers, Open Systems servers, and NEC D-Series storage arrays. The company's System64 product line consolidates z/OS, Windows, and Linux operating system in one secure and reliable operating environment based on Intel Itanium 2 processor technology. Platform Solutions has a strategic partnership with T3 Technologies. The company was founded in 1999 and is based in Sunnyvale, California. As of June 30, 2008, Platform Solutions, Inc. operates as a subsidiary of International Business Machines Corp.

Braze

Series D in 2017
Braze is a comprehensive customer engagement platform that powers relevant and memorable experiences between consumers and the brands they love. Context underpins every Braze interaction, helping brands foster human connection with consumers through interactive conversations across channels that deliver value quickly and continuously. The company was named a Leader in the 2019 Gartner Magic Quadrant for Mobile Marketing Platforms and was recognized as one of Inc Magazine's 2019 Best Workplaces. Braze is headquartered in New York with offices in Chicago, London, San Francisco, and Singapore. Learn more at braze.com.

Doximity

Series B in 2012
Founded in 2011, Doximity connects physicians and clinicians to make them more successful and productive. It is the largest professional medical network with over 70 percent of all U.S. physicians as members. The network enables medical professionals to communicate with colleagues and patients, and to share their perspectives on the latest health care trends and research. Doximity is based in San Francisco and was created by the founders of Epocrates and Rock Health. To learn more, visit www.doximity.com

Cebix

Venture Round in 2010
Cebix is focused on the development of chronic replacement therapy based on human proinsulin C-peptide for the treatment of type 1 diabetic neuropathy. The role of C-peptide will also be explored in type 1 diabetic nephropathy and retinopathy.

Gobiquity, Inc.

Series B in 2016
Gobiquity, Inc. provides prescribed mobile health applications for the early detection and prevention of health disorders and chronic diseases. It offers GoCheck Kids, a smartphone app that detects amblyopia risk factors and meets the American Association for Pediatric Ophthalmology and Strabismus guidelines for vision screening in children. Gobiquity, Inc. was formerly known as ICHECK Health Connection, Inc. The company was founded in 2010 and is based in Aliso Viejo, California.

Myogen

Series D in 2001
Myogen is a biopharmaceutical company focused on the discovery, development and commercialization of small molecule therapeutics for the treatment of cardiovascular disorders. They believe that our advanced understanding of the biology of cardiovascular disease combined with their clinical development expertise in cardiovascular therapeutics provide us with the capability to discover novel therapies, as well as identify, license or acquire products that address serious, debilitating cardiovascular disorders that are not adequately treated with existing therapies.

Tesaro, Inc.

Post in 2016
Founded in 2010, TESARO is a privately held oncology-focused biopharmaceutical company dedicated to improving the lives of cancer patients. The Company intends to leverage the experience and competencies of its management team to identify, acquire and develop promising drug candidates; and to commercialize safer and more effective products for the treatment and support of cancer patients. TESARO is developing rolapitant, a potent, selective neurokinin-1 receptor antagonist that has completed Phase 2 clinical testing for the prevention of chemotherapy induced nausea and vomiting, and is advancing its ALK inhibitor program for oncology indications. Phase 3 clinical testing of rolapitant is planned to commence during 2011 and the first ALK inhibitor clinical trial is targeted to begin in 2012. TESARO was co-founded by former executives of MGI PHARMA, an oncology and acute-care focused biopharmaceutical company that Eisai Co., Ltd. acquired in 2008 for $3.9 billion. TESARO is headquartered in Waltham, Massachusetts.

Covaro Networks

Series A in 2002
Covaro Networks develops telecommunications products for converged networks, enabling network infrastructure providers to unlock stranded profits while using high bandwidth services and containing capital and operating expenditures.

Pivot3

Venture Round in 2013
Global Hyper-Converged Infrastructure

Spredfast

Series C in 2013
Spredfast, Inc. provides a social relationship platform that allows enterprise brands and organizations to manage, monitor, and measure their social media programs in the United States and internationally. The company was formerly known as Social Agency, Inc. and changed its name to Spredfast, Inc. in January 2010. Spredfast, Inc. was founded in 2008 and is based in Austin, Texas with an additional office in London, United Kingdom. As of October 2, 2018, Spredfast, Inc. operates as a subsidiary of Lithium Technologies Inc.

Pivot3

Series C in 2008
Global Hyper-Converged Infrastructure
Aspreva Pharmaceuticals Corp is an emerging pharmaceutical company headquartered in Victoria, British Columbia focused on identifying, developing and commercializing new indications for approved drugs and drug candidates for underserved patient populations. Their strategy, which they call “indication partnering”, is to collaborate with pharmaceutical and biopharmaceutical companies to pursue new indication approvals which lie beyond their strategic focus.
QuatRx Pharmaceuticals Company, a biopharmaceutical company, engages in discovering, licensing, developing, and commercializing compounds in the areas of endocrine, metabolic, and cardiovascular therapeutics. Its products include Osphena for the treatment for vaginal atrophy, a common problem associated with estrogen deficiency in post-menopausal women. QuatRx Pharmaceuticals Company was founded in 2000 and is based in Ann Arbor, Michigan.
INVIDI Technologies Corporation provides software applications that track targeted advertising. It offers Advatar, a digital set-top box application that delivers addressable targeted advertising and marketing messages to individual viewers. It facilitates the sales of digital products, digital tiers, and digital services, such as VOD, PVR, and pay-per-view events; Internet, voice, and wireless services; and triple play offers. Advatar serves multi-channel video programming distributors, marketers, advertisers, and media buyers and sellers. The company also provides INVIDI Advertising Decision System, an addressable television advertising technology for managing advertising decisions and selections for household delivery in the evolving business of television advertising. INVIDI Technologies Corporation was founded in 2000 and is headquartered in Princeton, New Jersey.

Spredfast

Series B in 2011
Spredfast, Inc. provides a social relationship platform that allows enterprise brands and organizations to manage, monitor, and measure their social media programs in the United States and internationally. The company was formerly known as Social Agency, Inc. and changed its name to Spredfast, Inc. in January 2010. Spredfast, Inc. was founded in 2008 and is based in Austin, Texas with an additional office in London, United Kingdom. As of October 2, 2018, Spredfast, Inc. operates as a subsidiary of Lithium Technologies Inc.

Concept.io

Series A in 2013
Concept.io is the creator of Swell Radio, a delightful mobile app that streams personalized audio news and information. Swell helps users discover new content and expand their minds on the go. Concept.io strives to connect people with ideas and knowledge efficiently so we can all be more productive with our time. Concept.io is a technology startup funded by top-tier venture firms. The founding team consists of experienced entrepreneurs with a successful track record.

Avera Pharmaceutical

Series B in 2003
Avera Pharmaceuticals is a specialty pharmaceutical company that acquires, develops, and commercializes pharmaceutical compounds. The company develops gantacurium, a neuromuscular blocking agent for rapid and routine endotracheal intubation and skeletal muscle relaxation during surgery; AV810 for the treatment of overactive bladder and irritable bowel syndrome; and AV965 to treat cognitive impairment associated with schizophrenia and Alzheimer’s dementia. The company was founded in 2002 and is headquartered in San Diego, California.

Spredfast

Series D in 2014
Spredfast, Inc. provides a social relationship platform that allows enterprise brands and organizations to manage, monitor, and measure their social media programs in the United States and internationally. The company was formerly known as Social Agency, Inc. and changed its name to Spredfast, Inc. in January 2010. Spredfast, Inc. was founded in 2008 and is based in Austin, Texas with an additional office in London, United Kingdom. As of October 2, 2018, Spredfast, Inc. operates as a subsidiary of Lithium Technologies Inc.

Ophthonix

Series C in 2005
Ophthonix, Inc. manufactures and markets high resolution spectacle lenses for vision assessment and correction applications. It offers its high resolution lenses for single vision spectacle lenses for the correction of myopia, hyperopia, and mild astigmatism; and progressive addition spectacle lenses. The company sells its products through practitioners in the United States and European countries. Ophthonix, Inc. was founded in 2000 and is based in Vista, California.

Eiger BioPharmaceuticals

Debt Financing in 2016
Eiger BioPharmaceuticals is a privately held biotechnology company that develops a novel antiviral therapy for Hepatitis Delta, a life-threatening, Orphan Disease with high unmet medical need and no approved therapy. The company is led by a management team experienced in the development and commercialization of rare disease therapeutics. Its strategy is predicated upon time and cost-efficient drug development, with the goal of delivering safe and effective therapies to patients.

Ample Communications

Series C in 2004
As of September 25, 2007, Ample Communications, Inc. was acquired by Mindspeed Technologies, Inc. Ample Communications, Inc. develops silicon solutions for optimizing networking infrastructure. The company provides Ethernet MACs for increasing the performance of enterprise and wide-area networks. It offers integrated MACs that optimize Ethernet aggregation, as well as Gigabit Ethernet silicon solutions for the PC market. The company provides its products for various applications, including Ethernet switches and routers, Internet appliances, access devices in enterprise and metro applications, IPTV equipment, metro Ethernet, wireless/cellular backhaul, and Ethernet over SONET applications. Ample Communications, Inc. was founded in 2000 and is headquartered in Fremont, California.

Restoration Robotics

Venture Round in 2016
Restoration Robotics is a privately held medical device company, is dedicated to revolutionizing the field of hair transplantation by developing and commercializing a state-of-the-art image-guided system (ARTAS™ System) that enables follicular unit extraction.

eNeura Therapeutics

Series A in 2002
ENeura Therapeutics is a medical technology company developing transcranial magnetic stimulation devices for the treatment of migraines. It pioneers the use of portable, non-invasive Transcranial Magnetic Stimulation (TMS) devices for the treatment of migraine. Prescribed by physicians but designed for patient use, it is the first truly portable, convenient TMS product that will allow migraine patients to administer treatment as needed—at home, in the office, or on the go.

Open Silicon

Series C in 2005
Open-Silicon provides leading edge SoC and Custom IC design, open market IP integration, and high-quality silicon manufacturing services to customers worldwide. As a fabless company, Open-Silicon focuses on delivering the most cost-effective, predictable and reliable custom SoC solutions. The company partner with customers using flexible models that sometimes include full turnkey development from spec handoffs, and sometimes include only manufacturing services to take advantage of volume foundry, test, and packaging pricing. Since its founding in 2003, the company has focused on raising the bar on SoC execution, measuring the quality of engineering work and ability to hit customer schedules and reporting that to the board of directors at every board meeting.

NovaCardia

Series B in 2007
NovaCardia is a product-focused pharmaceutical company with significant capabilities and experience in cardiovascular drug development. The company is committed to improving the quality of care for patients with cardiovascular disease by developing and commercializing a portfolio of novel small molecule drugs. NovaCardia will be focused initially on the acute cardiac care marketplace.

Quickshift

Seed Round in 2005
QuickShift provides us with most of our warehousing and fulfillment services along with fleet support for distribution

NexPlanar Corporation

Series C in 2008
NexPlanar Corporation builds chemical mechanical planarization pads for the semiconductor device industry. The company provides hard and mid-hard, and ultra-soft pads. It serves semiconductor fabrication operations around the world. NexPlanar Corporation was formerly known as Neopad Technologies Corporation and changed its name to NexPlanar Corporation in September 2008. The company was founded in 2003 and is based in Hillsboro, Oregon. As of October 22, 2015, NexPlanar Corporation operates as a subsidiary of Cabot Microelectronics Corporation.

Quantance

Series D in 2013
Quantance is a fabless semiconductor company enabling a major breakthrough in data speed and battery life in mobile devices. Quantance's patented RF technology enables users to transmit more signal power from their mobile devices and data cards, which enhances data performance without adversely impacting battery life or requiring any changes to wireless network infrastructure.

Spiration

Series F in 2006
Spiration, Inc., doing business as Olympus Respiratory America, develops medical devices for the treatment of air leaks and lung diseases. The company was founded in 1999 and is based in Redmond, Washington. As of 2010, Spiration, Inc. operates as a subsidiary of Olympus America Inc.

Quantance

Series A in 2006
Quantance is a fabless semiconductor company enabling a major breakthrough in data speed and battery life in mobile devices. Quantance's patented RF technology enables users to transmit more signal power from their mobile devices and data cards, which enhances data performance without adversely impacting battery life or requiring any changes to wireless network infrastructure.

Avaak

Series A in 2008
Avaak is a provider of wireless video networking technology. Their applications are used in a variety of environments, from businesses to the military. The company is venture backed, and initially developed its wire-free video networking technology with sponsorship from DARPA and the Office of Naval Research (ONR).

Scale8

Series C in 2001
Scale8 is a San Francisco-based data storage service provider.

NexPlanar Corporation

Series C in 2008
NexPlanar Corporation builds chemical mechanical planarization pads for the semiconductor device industry. The company provides hard and mid-hard, and ultra-soft pads. It serves semiconductor fabrication operations around the world. NexPlanar Corporation was formerly known as Neopad Technologies Corporation and changed its name to NexPlanar Corporation in September 2008. The company was founded in 2003 and is based in Hillsboro, Oregon. As of October 22, 2015, NexPlanar Corporation operates as a subsidiary of Cabot Microelectronics Corporation.

CardioMind

Venture Round in 2008
CardioMind, Inc. Inc manufactures therapeutic devices for cardiovascular diseases. The company also offers stent delivery systems, which are designed for use in lesion applications, as well as for the treatment of coronary and peripheral artery diseases. In addition, it provides invasive endovascular medical devices for treating neurological and cardiovascular diseases. The company was founded in 2003 and is based in Sunnyvale, California.

Flurry, Inc.

Series B in 2010
Flurry is an application that provides analytics for businesses to monitor the trends and habits of mobile users across multiple mobile applications. Flurry’s mobile analytics solution enables businesses to understand how consumers interact with their mobile applications. Over 125,000 companies use Flurry’s analytics platform in more than 400,000 applications to measure audience reach, engagement, retention, conversions, revenue, and more. The service is completely free, takes just five minutes for basic integration, and is continuously updated with the industry's advanced features. Flurry Analytics is available for iOS, Android, Windows Phone, HTML5, hybrid apps, mobile/web, Blackberry, and JavaME.

Motiva

Series C in 2001
Motiva, Inc. is the technology leader for global enterprise incentive management (EIM) software and services, enabling companies to create and manage flexible, highly targeted incentive programs that drive top-line and bottom-line results across the extended enterprise. The Motiva software solution allows businesses to rapidly align performance with strategic objectives for sales, services, channels, customers and suppliers. Founded in 1996, Motiva is headquartered in Pleasanton, California.

Welltok

Series E in 2016
Welltok is a data-driven, enterprise SaaS company that delivers the healthcare industry’s leading consumer activation platform. Welltok’s solutions empower health plans, employers, providers, and public entities to connect consumers with personalized health improvement resources, making it easy and rewarding for consumers to complete actions that optimize their health and wellbeing. The company was founded in 2009 and headquartered in Denver, Colorado.

Sera Prognostics

Series A in 2011
Sera Prognostics, Inc., a biotechnology company, develops diagnostic tests for the early prediction of a woman’s individualized risk of premature birth, preeclampsia, and other pregnancy complications. It focuses on addressing the economic and healthcare burden that premature birth places on infants, their families, and society. Sera Prognostics, Inc. was founded in 2008 and is based in Salt Lake City, Utah.

Varolii

Series C in 2002
Varolii is the market and technology leader in proactive outbound communications. Its on-demand communication software and services help organizations more effectively reach and interact with their customers and employees, getting the best result from every interaction. By automating the processes required for personalized communications such as flight cancellation notices, fraud detection alerts and prescription pick-up reminders, Varolii helps its clients reduce operational costs, increase contact center efficiency, and get more out of their existing IT investments. More than 380 companies, including many of the largest U.S. banks, airlines, wireless carriers, utilities, and healthcare organizations trust Varolii to send 4 million communications every business day. Varolii is headquartered in Seattle with offices in the Boston and Denver metropolitan areas. Varolii was acquired by Nuance Communications (NASDAQ: NUAN) in October 2013 for an undisclosed price.

CVRx, Inc.

Series D in 2007
CVRx is a medical device company that develops implantable technology for the treatment of high blood pressure. Its products include Rheos implantable pulse generator that provides control and delivery of the activation energy; and Rheos carotid sinus leads, which conducts activation energy from the Rheos implantable pulse generator to the left and right carotid arteries. The company also offers a Rheos programmer system that communicates with the Rheos pulse generator. CVRx was founded in 2001 and is based in Minneapolis, Minnesota.

AkaRx

Series A in 2005
AkaRx, Inc., a biopharmaceutical company, develops therapeutic treatments for unmet medical needs. Its product includes AKR-501, an orally-available small molecule for use in the treatment of thrombocytopenia. The company was founded in 2005 and is headquartered in Paramus, New Jersey.

Myogen

Series D in 2003
Myogen is a biopharmaceutical company focused on the discovery, development and commercialization of small molecule therapeutics for the treatment of cardiovascular disorders. They believe that our advanced understanding of the biology of cardiovascular disease combined with their clinical development expertise in cardiovascular therapeutics provide us with the capability to discover novel therapies, as well as identify, license or acquire products that address serious, debilitating cardiovascular disorders that are not adequately treated with existing therapies.

Lycera

Series A in 2009
Lycera Corp., a biopharmaceutical company, develops small molecule immunomodulatory medicines for the treatment of autoimmune diseases and cancer. It offers LYC-55716, a multiple anti-tumor mechanism into a single therapeutic by modulating gene expression to reprogram immune cells for improved function, as well as decrease immunosuppressive mechanisms; and ATPase Modulators, a therapy for autoimmune diseases. Lycera Corp. was founded in 2006 and is based in Ann Arbor, Michigan with additional offices in New York, New York; and Plymouth Meeting, Pennsylvania.

Corixa Corp

Series A in 1995
Corixa is a developer of immunotherapeutics with a commitment to treating and preventing autoimmune diseases, cancer and infectious diseases by understanding and directing the immune system. Having founded in 1994, the company conducted various preclinical development programs, including the BEXXAR® therapy and the MELACINE® vaccine. Corixa is focused on immunotherapeutic products and has a broad technology platform enabling both fully integrated vaccine design and the use of its separate, proprietary product components on a standalone basis. The company partners with numerous developers and marketers of pharmaceuticals, targeting products that are powered by Corixa™ technology with the goal of making its potential products available to patients around the world. Corixa was acquired by GlaxoSmithKline on 12 July 2005, and GSK had formerly made use of the Corixa's MPL adjuvant in some of their vaccines. The company ceased operations in March 2006.
Centrexion Therapeutics is focused on developing new therapies for moderate to severe chronic pain that address the safety and efficacy gaps in the current treatment paradigm.We aim to relieve the suffering associated with chronic pain by creating treatments that address the safety and efficacy gaps in the current treatment paradigm.

AkaRx

Series A in 2006
AkaRx, Inc., a biopharmaceutical company, develops therapeutic treatments for unmet medical needs. Its product includes AKR-501, an orally-available small molecule for use in the treatment of thrombocytopenia. The company was founded in 2005 and is headquartered in Paramus, New Jersey.

Aryaka Networks

Series C in 2014
[Aryaka](http://www.aryaka.com)'s Global SD-WAN provides optimized, software-defined network connectivity and application acceleration to globally distributed enterprises. Aryaka’s services have over 10 million users across more than 4,000 sites. Leading brands such as Skullcandy, Air China, Freescale Semiconductor, and ThoughtWorks, as well as partners such as Microsoft Azure, AWS, Intelisys, and SK Broadband, have all chosen Aryaka for their enterprise-grade networking needs.

Achates Power, Inc.

Series D in 2017
Achates Power specializes in the fields of combustion engine development, clean diesel, and 2-stroke oil control management. The company is on a mission to build better, more efficient engines, the company has an experienced staff of engineers and scientists focused on applying their proven technical know-how and expertise, coupled with the industry's leading-edge testing, simulation, and analysis tools. it was founded in 2004 and headquartered in San Diego, California.

Kajeet

Series B in 2007
Kajeet, the industry leader for safe, mobile student Internet connectivity, is closing the Homework Gap in school districts across the country. Kajeet provides an affordable mobile broadband solution that connects low-income students to the resources needed to complete homework. The Kajeet SmartSpot® (a portable Wi-Fi hotspot), and the Kajeet SmartBus™ (school bus Wi-Fi) solutions combined with the innovative Sentinel® cloud portal, enables administrators and teachers to provide CIPA-compliant, customizable filtered Internet access that keeps students focused on school work and provides mobile Internet connectivity for education without worry of data abuse.

Optimizely, Inc.

Seed Round in 2012
Optimizely is provides customer experience optimization, allowing businesses to dramatically drive up the value of their digital products, commerce, and campaigns through its best in class experimentation software platform. By replacing digital guesswork with evidence-based results, Optimizely enables product and marketing professionals to accelerate innovation, lower the risk of new features, and drive up the return on investment from digital by up to 10X. Over 26 of the Fortune 100 companies choose Optimizely to power their global digital experiences. Optimizely’s impressive customer list includes eBay, FOX, IBM, The New York Times, and many more global enterprises. Optimizely was founded in 2009 and is headquartered in San Francisco, California.

Crowdpac, Inc.

Seed Round in 2014
Crowdpac is the first crowdfunding platform designed for politics helping candidates, organizations, and ordinary citizens fund the change they want to see. They use the best technology and objective data to boost political participation, helping citizens to vote, by understanding the candidates on their ballot; to fund political change through crowdfunding tools, and helping anyone run for office by raising money and mobilizing support independent of big donors and special interests. It was founded is 2013 and is headquartered in San Francisco, California.

Silicon Optix

Series C in 2004
Silicon Optix is a fabless semiconductor company, supplier of warping integrated circuit (IC) technology – eWARP™. eWARP digital distortion correction allows manufacturers to complement optics with sophisticated electronics imaging in order to achieve superior system designs and add new compelling features to products while reducing cost and complexity of optical systems. Silicon Optix has the only mainstream geometry processing IC in volume production to date. Over seven years of research and development invested in IC design, system design and optics have given Silicon Optix the expertise to be the leader in this emerging technology with large market opportunities.

Chiaro Networks

Series C in 2000
Chiaro Networks, Inc. engages in the design, manufacture, and delivery of Internet protocol/multi protocol label switching in the United States.

Gynesonics

Debt Financing in 2014
Gynesonics, Inc. designs and develops minimally invasive solutions for symptomatic uterine fibroids in women. The company offers Sonography-Guided Transcervical Fibroid Ablation (Sonata) System(The Sonata System) for the transcervical treatment of symptomatic uterine fibroids under intrauterine sonography guidance serving customers in the European Union. Gynesonics, Inc. was founded in 2005 and is based in Redwood City, California with an additional location in Beuningen, the Netherlands.

Fluidigm

Venture Round in 2009
Fluidigm Corporation develops and distributes systems based on the properties of integrated fluidic circuits to control precisely fluids on a nano volume scale. The company's product line includes the TOPAZ system, which is used for protein crystallization; and the BioMark system, which is used for genetic analysis. Fluidigm Corporation was founded as Mycometrix Corporation in 1999 and was renamed as Fluidigm Corporation in 2001. The company is based in San Francisco, California.

MacroGenics

Series C in 2006
MacroGenics, Inc., a biotechnology company, focuses on the development, manufacture, and commercialization of immunotherapeutics for autoimmune disorders, cancer, and infectious diseases. The company is developing immune-based products, including monoclonal antibodies; and vaccines to prevent infections in healthy individuals. The company's Fc engineering technology enables to improve antibody functions to eliminate cancer cells. It is also developing products around the Dual Activating ReTargeting technology. The company was founded in 2000 and is headquartered in Rockville, Maryland.

Intarcia Therapeutics

Series E in 2004
Intarcia Therapeutics is a biopharmaceutical company that develops therapies for diseases that require long-term chronic treatment. It offers DUROS, a drug delivery platform that stabilizes and delivers therapeutic proteins and peptides. Intarcia Therapeutics' products include OMEGA DUROS, an interferon delivery device for treating Hepatitis C and ITCA 650, a delivery device that provides type 2 diabetes patients with long-term steady state dosing of an incretin mimetic therapy. Additionally, it develops programs for treating obesity. David Franklin, James M. Ahlers, and Thomas Alessi founded BioMedicines in 1997 that became Intarcia Therapeutics in September 2004. Its headquarters is in Hayward in California with an additional office in Mountain View in California.

Hangtime

Seed Round in 2013
Hangtime, the company intent on upgrading your social life, launched the first and only app that lets you see what your friends are doing in the future, eliminating the millions of missed opportunities to be with friends. With Hangtime, individuals can easily see friends’ social future – from concerts to poetry readings and more – so they can find new ways to hang out together. Hangtime is available on the iPhone, Facebook and other mobile devices, Hangtime gives users plenty of time to discover friends’ plans and join in activities that interest them most.

Nuventix

Series A in 2005
Nuventix is an active thermal management solutions company located in Austin, Texas. The Nuventix-developed SynJet® module is a newly patented synthetic jet cooling technology that utilizes turbulent pulses of air generated from an electromagnetic actuator. Based on early success with computer cooling, Nuventix's innovative approach to LED cooling is propelling that market forward two years ahead of analyst estimates - truly affecting the industry and allowing general illumination designs to harvest the efficiencies of the LED.
PrimeraDx, Inc. offers multiplexed infectious disease assays. It provides Scalable Target Amplification Routine technology, which is a method for simultaneous quantitative measurement of multiple target nucleic acids. The company also offers ViraQuant, a multiplexed assay providing quantitative and simultaneous measurement of viruses; and FungiQuant Yeast and FungiQuant Mold, which are fungal panels for mycology testing. Its products are used in miRNA, DNA methylation, quantitative genotyping, gene expression, and viral load measurement applications. PrimeraDx, Inc. was founded in 2004 and is based in Mansfield, Massachusetts.

GoToMyDoc

Venture Round in 2000
GoToMyDoc lets you go to your doc directly, where you'll find information and use our personalized tools to learn more about pregnancy, midlife, and many more women's health topics. Or benefit from our easy to use, timesaving patient services like online prescription renewals, appointment scheduling, test preparation tips . . . and much more.

LoanCity.com

Series B in 1999
LoanCity.com, a large source of online residential mortgage loans for brokers.

Alt12 Apps, LLC

Seed Round in 2012
Alt12 Apps is the leading developer of cross-platform mobile apps for women. Utilizing Sliprose™, a proprietary framework, the company delivers award-winning apps with rich native experiences, an integrated mobile community, compelling content and elegant design. Alt12 launched in 2009 with BabyBump™ the first pregnancy app to be deployed on multiple mobile platforms and the number premium pregnancy mobile app in the world. Alt12 Apps is headquartered in San Francisco, California.

Victorious

Series A in 2014
Victorious empowers creators to distribute all of their multimedia content in their own apps, interact more deeply and directly with their fan communities, and unlock new revenue streams. The company was founded in 2013 and is based in Santa Monica, California.

Braze

Series C in 2016
Braze is a comprehensive customer engagement platform that powers relevant and memorable experiences between consumers and the brands they love. Context underpins every Braze interaction, helping brands foster human connection with consumers through interactive conversations across channels that deliver value quickly and continuously. The company was named a Leader in the 2019 Gartner Magic Quadrant for Mobile Marketing Platforms and was recognized as one of Inc Magazine's 2019 Best Workplaces. Braze is headquartered in New York with offices in Chicago, London, San Francisco, and Singapore. Learn more at braze.com.

Canva, Inc.

Seed Round in 2013
Canva is a graphic design software solutions provider that helps users to design presentations, social media graphics, and more with various layouts, images, photo filters, icons and shapes, and fonts. The platform combines a drag-and-drop design tool with a stock library of photographs, illustrations, and imagery. The company is on a mission to simplify the process of graphic design for photographers, illustrators, and designers globally. Canva was established in 2012 and is based in Sydney, Australia.

NewsCred

Venture Round in 2019
NewsCred, the global leader in enterprise content marketing, empowers the world’s most ambitious brands with powerful technology, the largest and most diverse content offerings, and proven, unrivaled expertise. Through its complete solution, NewsCred offers a repeatable methodology that guarantees ROI for the world’s leading CMOs and marketing leaders from companies including Barclays, Cox Communications, Fidelity, HPE, USAA, Virgin Media, and more. Founded in 2008, NewsCred serves hundreds of customers in over 70 countries from seven global offices. Learn more at NewsCred.com, join our community at NewsCred Insights and follow us on Twitter and LinkedIn.

The RealReal, Inc.

Series C in 2014
The RealReal, Inc. operates an online marketplace for consigned luxury goods. It offers various resale product categories, including women’s, men’s, kids’, jewelry, and watches, as well as home and art products. The company was founded in 2011 and is headquartered in San Francisco, California.

Anesiva

Series D in 2003
Anesiva, Inc., a biopharmaceutical company, engages in the development and commercialization of novel therapeutic treatments for pain management worldwide. Its lead product candidate includes Adlea, which completed multiple Phase II and Phase III trials for post-surgical, musculoskeletal, and neuropathic pain. The company was formerly known as AlgoRx Pharmaceuticals, Inc., it changed its name to Anesiva, Inc. in 2006. Anesiva, Inc. was founded in 1999 and is headquartered in South San Francisco, California. On January 15, 2010, Anesiva, Inc. filed a voluntary petition for liquidation under Chapter 7 in the U.S. Bankruptcy Court for the Northern District of California. On June 10, 2014 filed for Chapter 7 bankruptcy.

Spiration

Series G in 2008
Spiration, Inc., doing business as Olympus Respiratory America, develops medical devices for the treatment of air leaks and lung diseases. The company was founded in 1999 and is based in Redmond, Washington. As of 2010, Spiration, Inc. operates as a subsidiary of Olympus America Inc.

Restoration Robotics

Series C in 2014
Restoration Robotics is a privately held medical device company, is dedicated to revolutionizing the field of hair transplantation by developing and commercializing a state-of-the-art image-guided system (ARTAS™ System) that enables follicular unit extraction.

Triposo

Series A in 2012
Triposo, Inc. develops interactive travel guides for the mobile devices. It offers country maps, and language and city guides. The company also provides background information on the country, culture, and history; descriptions; list of restaurants, bars, and nightclubs; hiking, biking, or relaxing activities information; and offline maps. Triposo, Inc. was founded in 2010 and is based in Amersfoort, the Netherlands. As of October 10, 2017, Triposo, Inc. operates as a subsidiary of Musement S.r.l.

Fluidigm

Series D in 2005
Fluidigm Corporation develops and distributes systems based on the properties of integrated fluidic circuits to control precisely fluids on a nano volume scale. The company's product line includes the TOPAZ system, which is used for protein crystallization; and the BioMark system, which is used for genetic analysis. Fluidigm Corporation was founded as Mycometrix Corporation in 1999 and was renamed as Fluidigm Corporation in 2001. The company is based in San Francisco, California.

ReVision Optics

Venture Round in 2016
ReVision Optics, Inc. designs, manufactures, and delivers implantable products for the treatment of presbyopia. It offers PRESBYLENS Corneal Inlay, a refractive surgery solution to correct vision lost by the natural aging process called presbyopia. The company serves the ophthalmology professionals. ReVision Optics, Inc. was formerly known as IntraLens Vision, Inc. and changed its name to ReVision Optics, Inc. in 2005. The company was founded in 1996 and is based in Lake Forest, California.

Avedro

Series E in 2015
Medical device and pharmaceutical company advancing the science and technology of corneal cross-linking

NeuroPace

Venture Round in 2005
NeuroPace, Inc. designs, develops, manufactures, and markets implantable devices for the treatment of neurological disorders with responsive stimulation. It offers RNS System, a medical device that monitors and responds to brain activity. The company’s RNS System consists of a small implantable neuro stimulator that is connected to leads that are placed in up to two seizure onset areas. NeuroPace, Inc. was founded in 1997 and is based in Mountain View, California.

Cape Clear Software

Series D in 2006
Cape Clear Software, Inc. provides services-oriented architecture (SOA) and enterprise service bus (ESB) technology. Its products include Server, a runtime engine that supports service hosting, of BPEL, Java, assembly, and database services; and multiple transports out-of-the-box; Studio, an Eclipse-based tools environment for the development of SOA-based and on-demand applications; and SOA Assembly for service implementation, manipulation of message parts, and handling of error conditions, as well as application of routing, splitting, and load-balancing rules.

IntraLens Vision

Series C in 2005
ReVision Optics, Inc. designs, manufactures, and delivers implantable products for the treatment of presbyopia. It offers PRESBYLENS Corneal Inlay, a refractive surgery solution to correct vision lost by the natural aging process called presbyopia. The company serves the ophthalmology professionals. ReVision Optics, Inc. was formerly known as IntraLens Vision, Inc. and changed its name to ReVision Optics, Inc. in 2005. The company was founded in 1996 and is based in Lake Forest, California.

Doximity

Series A in 2011
Founded in 2011, Doximity connects physicians and clinicians to make them more successful and productive. It is the largest professional medical network with over 70 percent of all U.S. physicians as members. The network enables medical professionals to communicate with colleagues and patients, and to share their perspectives on the latest health care trends and research. Doximity is based in San Francisco and was created by the founders of Epocrates and Rock Health. To learn more, visit www.doximity.com

Ample Communications

Series A in 2000
As of September 25, 2007, Ample Communications, Inc. was acquired by Mindspeed Technologies, Inc. Ample Communications, Inc. develops silicon solutions for optimizing networking infrastructure. The company provides Ethernet MACs for increasing the performance of enterprise and wide-area networks. It offers integrated MACs that optimize Ethernet aggregation, as well as Gigabit Ethernet silicon solutions for the PC market. The company provides its products for various applications, including Ethernet switches and routers, Internet appliances, access devices in enterprise and metro applications, IPTV equipment, metro Ethernet, wireless/cellular backhaul, and Ethernet over SONET applications. Ample Communications, Inc. was founded in 2000 and is headquartered in Fremont, California.

Cheetah Digital

Series A in 2016
Cheetah Digital is a cross-channel customer engagement solution provider for the modern marketer. Unlike walled garden marketing clouds and IT-centric CDPs, the Cheetah Digital Customer Engagement Suite enables marketers to drive revenue, build lasting customer relationships, and deliver a unique value exchange throughout the entire customer lifecycle. Enterprise brands can create personalized experiences, cross-channel messaging, and loyalty strategies, underpinned by our engagement data platform that can scale to meet the changing demands of today's consumer.

Participate Systems

Series A in 1999
Participate Systems provides outsourced online sales and customer support community solutions. The platform offers self-help solutions, software and management services, monthly and quarterly reports, and operating plans.

Quantance

Series B in 2008
Quantance is a fabless semiconductor company enabling a major breakthrough in data speed and battery life in mobile devices. Quantance's patented RF technology enables users to transmit more signal power from their mobile devices and data cards, which enhances data performance without adversely impacting battery life or requiring any changes to wireless network infrastructure.

Cape Clear Software

Series E in 2007
Cape Clear Software, Inc. provides services-oriented architecture (SOA) and enterprise service bus (ESB) technology. Its products include Server, a runtime engine that supports service hosting, of BPEL, Java, assembly, and database services; and multiple transports out-of-the-box; Studio, an Eclipse-based tools environment for the development of SOA-based and on-demand applications; and SOA Assembly for service implementation, manipulation of message parts, and handling of error conditions, as well as application of routing, splitting, and load-balancing rules.

Tizona Therapeutics, Inc.

Series A in 2016
The company is establishing collaborations with its scientific founders “to better understand whether regulatory T cells play a more prominent role in certain tumors,” he added. Although research suggests that Tregs cells play a more prominent role in creating immunosuppression in the microenvironment in some tumor types than others, “quite honestly, the data are lacking. One of the ways we’re going to differentiate the company is to understand that relationship better.

Lombardi Software

Series C in 2006
A suite of business process management software and services in the united states

IntraLase Corporation

Venture Round in 2000
IntraLase Corporation is a leader in the first step of LASIK surgery, the most common means of surgical vision correction. They design, develop and market a laser, related software and disposable devices used to create a cut of tissue across the cornea of a patient’s eye, or a corneal flap, which is the first step in LASIK surgery. Their advanced laser technology improves the safety, precision and visual acuity of LASIK surgery by providing a computer-controlled laser solution as an alternative to the traditional method of creating the corneal flap using a hand-held mechanical, metal-bladed device called a microkeratome. They believe their product offering will become the new standard of care for corneal flap creation. As of April 2, 2007, IntraLase Corp. was acquired by Advanced Medical Optics Inc.

Nereus Pharmaceuticals

Series D in 2007
Nereus Pharmaceuticals, Inc. engages in the discovery and development of therapeutics for the treatment of oncology, infectious diseases, and inflammation. The company uses its marine microbiology technologies for the discovery and development of drug candidates. Its oncology drug candidates include NPI-2358, a tumor vascular disrupting agent for the treatment of solid tumors; and NPI-0052, a proteasome inhibitor for the treatment of solid tumors, lymphomas, and multiple myeloma. The company was founded in 1998 and is based in San Diego, California.

Open Silicon

Series D in 2007
Open-Silicon provides leading edge SoC and Custom IC design, open market IP integration, and high-quality silicon manufacturing services to customers worldwide. As a fabless company, Open-Silicon focuses on delivering the most cost-effective, predictable and reliable custom SoC solutions. The company partner with customers using flexible models that sometimes include full turnkey development from spec handoffs, and sometimes include only manufacturing services to take advantage of volume foundry, test, and packaging pricing. Since its founding in 2003, the company has focused on raising the bar on SoC execution, measuring the quality of engineering work and ability to hit customer schedules and reporting that to the board of directors at every board meeting.

Achates Power, Inc.

Series C in 2013
Achates Power specializes in the fields of combustion engine development, clean diesel, and 2-stroke oil control management. The company is on a mission to build better, more efficient engines, the company has an experienced staff of engineers and scientists focused on applying their proven technical know-how and expertise, coupled with the industry's leading-edge testing, simulation, and analysis tools. it was founded in 2004 and headquartered in San Diego, California.

Fluidigm

Series E in 2007
Fluidigm Corporation develops and distributes systems based on the properties of integrated fluidic circuits to control precisely fluids on a nano volume scale. The company's product line includes the TOPAZ system, which is used for protein crystallization; and the BioMark system, which is used for genetic analysis. Fluidigm Corporation was founded as Mycometrix Corporation in 1999 and was renamed as Fluidigm Corporation in 2001. The company is based in San Francisco, California.

Calypso Medical

Series E in 2009
Calypso Medical Technologies is a Seattle-based, privately held medical device company. The Company's proprietary tumor localization system utilizes miniaturized implanted devices (Beacon® electromagnetic transponders) to continuously, accurately and objectively track the location of tumors for improved accuracy and management of radiation therapy delivery. The technology is designed for body-wide cancers commonly treated with radiation therapy. The products are FDA 510(k) cleared for use in the prostate and post-operative prostatic bed. The Company has strategic relationships with Varian Medical Systems, Siemens Medical Systems, Elekta Corporation, and Philips Medical.

Obalon Therapeutics, Inc.

Series C in 2012
Obalon is an engineering-driven medical technology company with a singular focus on innovative, high-quality gastric balloon technology. Located in San Diego, California, the technical team at Obalon has a long history of working closely with leading clinicians to develop innovative medical products that revolutionize the treatment of chronic disease. As a company, they believe in the fundamental value of imagination and invention, combined with rigorous testing and analysis, to ensure the highest levels of safety and performance. The result is a user-focused approach that deploys the power of advanced technological thinking to support clinical treatment objectives. It was founded in 2008.

Transcept Pharmaceuticals

Series D in 2007
Transcept Pharmaceuticals, Inc. uses its proprietary delivery system to enhance the penetration of drugs, significantly speeding their onset of action. Transcept is developing rapid-acting versions of several major market pharmaceuticals. Hamilton co-invested in the company's first institutional round of funding alongside Montreaux Equity Partners, Peninsula Equity Partners and Vivo Ventures. Investors in subsequent financing rounds include these firms, and New Leaf Venture Partners, Interwest Partners and New Enterprise Associates.

Khoros

Series B in 2011
Khoros is a computer software company that offers a customer engagement platform that turns siloed knowledge into enterprise value and customers into contributors. It enables companies the ability to run their business with their customers, anticipating their needs, accelerating sales, loyalty, and innovation.
Alvine Pharmaceuticals, Inc. is a privately held biopharmaceutical company dedicated to developing and commercializing therapeutics for autoimmune/gastrointestinal diseases. Alvine's lead product candidate, ALV003, is a combination protease engineered to digest gluten. It is being developed to treat patients with celiac disease.

Bivio Networks

Series A in 2000
Founded in 2000, Bivio Networks is dedicated to providing leading networking products that enable government agencies and service providers to control, monitor, and secure critical network infrastructure. A leader in cyber intelligence, cyber security and network control solutions, Bivio has deployed its products in a wide range of solutions. Bivio’s global customer base includes leading intelligence agencies, military organizations and service providers. Bivio is privately-held and is headquartered in the San Francisco Bay Area with office locations worldwide. Specialties Cyber Security, Cyber Intelligence, Deep Packet Inspection (DPI) Networking Systems, Mass Metadata Extraction and Analysis, Data Retention System, Cyber Investigation, network probe

NexPlanar Corporation

Series D in 2011
NexPlanar Corporation builds chemical mechanical planarization pads for the semiconductor device industry. The company provides hard and mid-hard, and ultra-soft pads. It serves semiconductor fabrication operations around the world. NexPlanar Corporation was formerly known as Neopad Technologies Corporation and changed its name to NexPlanar Corporation in September 2008. The company was founded in 2003 and is based in Hillsboro, Oregon. As of October 22, 2015, NexPlanar Corporation operates as a subsidiary of Cabot Microelectronics Corporation.

Piggybackr

Seed Round in 2013
Piggybackr built an online fundraising platform that is instructional, safe for all ages, and team focused. Because community crowdfunding really is a joint effort among friends, family, community members, local businesses, and brands passionately helping each other reach their fullest potential.

Totango Ltd.

Series C in 2016
Totango, Inc. develops an enterprise grade customer success platform that allows users to connect their customers’ data, monitor health changes, and engage their customers. The company offers Customer Success Centre, a solution for customer engagement; Zoe, a solution for enterprise impact; and DNA-CX, a solution for multidimensional customer context in real-time. Its solutions include voice of the customer, customer onboarding, customer adoption, customer renewal, and customer escalation. The company was founded in 2010 and is based in Redwood City, California. Totango, Inc. operates as a subsidiary of Totango Ltd.

Invuity

Venture Round in 2012
Invuity, Inc. develops visualization products for the less invasive surgical field applications. It offers BriteField Port System that provides illumination and visualization during minimally invasive procedures; and BriteField McCulloch retractor, which allows physicians to achieve visualization during surgery while using traditional techniques. Invuity, Inc. was formerly known as Spotlight Surgical Inc. The company was founded in 2004 and is headquartered in San Francisco, California.

Neuronetics

Series C in 2006
Neuronetics is focused on developing non-invasive therapies for psychiatric and neurological disorders using MRI-strength magnetic field pulses. They are the first and only company to have a non-systemic and non-invasive depression treatment cleared by the FDA for patients who have not benefited from prior antidepressant treatment. The company was founded in 2003 and is based in Malvern, Pennsylvania.

Sierra Logic

Series B in 2002
Sierra Logic was founded in 2001 by four veterans of storage silicon products, all formerly of HP and Agilent Technologies. Sierra Logic is currently operating in "quiet mode", and specific product plans are being shared with customers under NDA.

Gobiquity, Inc.

Series B in 2019
Gobiquity, Inc. provides prescribed mobile health applications for the early detection and prevention of health disorders and chronic diseases. It offers GoCheck Kids, a smartphone app that detects amblyopia risk factors and meets the American Association for Pediatric Ophthalmology and Strabismus guidelines for vision screening in children. Gobiquity, Inc. was formerly known as ICHECK Health Connection, Inc. The company was founded in 2010 and is based in Aliso Viejo, California.

Participate Systems

Series B in 2000
Participate Systems provides outsourced online sales and customer support community solutions. The platform offers self-help solutions, software and management services, monthly and quarterly reports, and operating plans.

NovaCardia

Series B in 2006
NovaCardia is a product-focused pharmaceutical company with significant capabilities and experience in cardiovascular drug development. The company is committed to improving the quality of care for patients with cardiovascular disease by developing and commercializing a portfolio of novel small molecule drugs. NovaCardia will be focused initially on the acute cardiac care marketplace.

Chiaro Networks

Series B in 2000
Chiaro Networks, Inc. engages in the design, manufacture, and delivery of Internet protocol/multi protocol label switching in the United States.

Flurry, Inc.

Series C in 2010
Flurry is an application that provides analytics for businesses to monitor the trends and habits of mobile users across multiple mobile applications. Flurry’s mobile analytics solution enables businesses to understand how consumers interact with their mobile applications. Over 125,000 companies use Flurry’s analytics platform in more than 400,000 applications to measure audience reach, engagement, retention, conversions, revenue, and more. The service is completely free, takes just five minutes for basic integration, and is continuously updated with the industry's advanced features. Flurry Analytics is available for iOS, Android, Windows Phone, HTML5, hybrid apps, mobile/web, Blackberry, and JavaME.

Eiger BioPharmaceuticals

Series A in 2009
Eiger BioPharmaceuticals is a privately held biotechnology company that develops a novel antiviral therapy for Hepatitis Delta, a life-threatening, Orphan Disease with high unmet medical need and no approved therapy. The company is led by a management team experienced in the development and commercialization of rare disease therapeutics. Its strategy is predicated upon time and cost-efficient drug development, with the goal of delivering safe and effective therapies to patients.

T-RAM Semiconductor

Series C in 2005
T-RAM Semiconductor is a fabless semiconductor company that has developed an innovative process based on TCCT (Thin-Capacitively-Coupled-Thyristor) technology, which produces a memory cell one-fourth to one-eighth the size of competing 6T-SRAM (Six Transistor-Static Random Access Memory) memory technology. T-RAM Semiconductor is using its proprietary TCCT technology advantage to produce both higher density and lower cost High Performance Synchronous SRAM's targeting the discrete and embedded memory needs of high- performance computer servers, networking, and telecom.

Triposo

Venture Round in 2015
Triposo, Inc. develops interactive travel guides for the mobile devices. It offers country maps, and language and city guides. The company also provides background information on the country, culture, and history; descriptions; list of restaurants, bars, and nightclubs; hiking, biking, or relaxing activities information; and offline maps. Triposo, Inc. was founded in 2010 and is based in Amersfoort, the Netherlands. As of October 10, 2017, Triposo, Inc. operates as a subsidiary of Musement S.r.l.

Labrys Biologics

Venture Round in 2012
Labrys Biologics Inc., a company focused on treatments for chronic migraine. Labrys Biologics has acquired worldwide rights to RN-307 from Pfizer Inc. RN-307 is an antibody for the treatment of chronic migraine.
Applied Genetics Technologies Corporation (AGTC) is developing therapies designed to transform the lives of patients with severe diseases, offering hope to patients with unmet medical needs. With a highly specialized team of physicians and researchers, They use cutting-edge techniques to develop treatments for patients that have diseases caused by broken genes. They use gene therapy, which replaces those broken genes with normal functional genes, allowing a patient’s own body to produce proteins to treat their illness. A single injection provides long-lasting treatment, leading to a better quality of life for patients worldwide.

HireArt, Inc.

Seed Round in 2013
HireArt is an online recruitment platform that engages in the pre-screening process for suitable job seekers. It improves the job candidate pre-screening process by creating online interviews that simulate a real job. The candidates are asked to complete tasks that are similar to what they would encounter on the job (e.g., give a presentation, do an excel analysis, give feedback). They record their responses over video or submit text answers and attachments, giving employers higher quality information on which to base hiring decisions. It was founded in 2012 and is headquartered in New York, New York.

Lombardi Software

Venture Round in 2004
A suite of business process management software and services in the united states

SchoolFeed

Seed Round in 2012
schoolFeed, a San Mateo, CA-based classmate network online. Launched in July 2011 by Lance Tokuda, schoolFeed connects online users between the ages of 35-55, who didn’t have social networks while in school, and may have difficulty locating classmates today. The classmate network offers an online yearbook and class directory with news feed, interest subscriptions and virtual currency. It is already used by over 7 million users

Cardiac Dimensions

Series D in 2007
Cardiac Dimensions, Inc., a medical device company, engages in the development of minimally invasive treatment modalities to address heart failure and related cardiovascular conditions. The company develops Carillon Mitral Contour System, a permanent implant for the treatment of functional mitral regurgitation. The company was incorporated in 2000 and is based in Kirkland, Washington with additional operations in Sydney, Australia and Offenbach, Germany.

Gear6

Venture Round in 2008
Gear6 sells Memcached solutions enabling high-growth web sites to deliver and scale dynamic applications and content. By focusing on the emerging need for a dedicated web caching tier, Gear6 solutions improve the scalability of web applications and databases, improving quality of service and reducing infrastructure cost.

Aria Systems, Inc.

Series F in 2017
Proven by the world's most demanding enterprises, including AAA NCNU, Constant Contact, Falck, Hootsuite, Pitney Bowes, Audi, Adobe, Telekom Denmark, Philips, Roku, and VMware, Aria helps enterprises grow their recurring revenue businesses. Aria helps clients take advantage of each customer-driven event − known as revenue moments − with agile billing, active customer engagement, and the rapid development of new products and services. With Aria's end-to-end active monetization platform, global brands can get to market faster with a wider variety of products and services, while maximizing customer satisfaction, retention, and lifetime value.

Vendavo, Inc.

Series B in 1999
Vendavo is the provider of price management and optimization software for business-to-business companies worldwide. The Vendavo Enterprise Pricing Suite solves pricing problems by giving businesses true enterprise-wide control of their entire pricing process. Vendavo combines pricing science, pricing best practices, and enterprise-class software to drive improvements in average prices at every stage of the pricing process, from segmentation to deal close. Added up, these improvements deliver significant increases in profits from 10% to 30%. Vendavo is the enterprise price management and optimization solution of choice for some of the worlds biggest companies in chemicals, high-tech, industrial manufacturing, consumer products, mill products and distribution. SAP, the worlds leading provider of business software, with more than 33,200 customers in more than 120 countries, sources its price and margin management solution from Vendavo. It is sold by SAP worldwide under the name SAP Price and Margin Management.

Gynesonics

Private Equity Round in 2018
Gynesonics, Inc. designs and develops minimally invasive solutions for symptomatic uterine fibroids in women. The company offers Sonography-Guided Transcervical Fibroid Ablation (Sonata) System(The Sonata System) for the transcervical treatment of symptomatic uterine fibroids under intrauterine sonography guidance serving customers in the European Union. Gynesonics, Inc. was founded in 2005 and is based in Redwood City, California with an additional location in Beuningen, the Netherlands.

Gojee

Venture Round in 2012
Gojee showcases the best recipes from the best food bloggers around the world. Gojee offers personalized recommendation to each person based on his/her personal tastes (craves, haves, dislikes). Available on the web, iPhone and iPad, Gojee is a pioneer in full-screen visual discovery and online recipe aggregation. Explore. Discover. Indulge.

Ample Communications

Series D in 2005
As of September 25, 2007, Ample Communications, Inc. was acquired by Mindspeed Technologies, Inc. Ample Communications, Inc. develops silicon solutions for optimizing networking infrastructure. The company provides Ethernet MACs for increasing the performance of enterprise and wide-area networks. It offers integrated MACs that optimize Ethernet aggregation, as well as Gigabit Ethernet silicon solutions for the PC market. The company provides its products for various applications, including Ethernet switches and routers, Internet appliances, access devices in enterprise and metro applications, IPTV equipment, metro Ethernet, wireless/cellular backhaul, and Ethernet over SONET applications. Ample Communications, Inc. was founded in 2000 and is headquartered in Fremont, California.

Satori Pharmaceuticals

Venture Round in 2012
Satori Pharmaceuticals is a neuroscience company focused on the discovery and development of disease-modifying therapies for Alzheimer's disease, Parkinson's disease and other neurodegenerative disorders.

Aviate

Venture Round in 2013
Aviate is an intelligent homescreen for the Android operating system that organizes the information in your phone and surfaces it at the perfect moment. Aviate works with your favorite apps to raise the smartphone experience above the clutter.

AdsNative

Series A in 2015
Polymorph powers the monetization infrastructure for modern enterprises. Polymorph is a white-label SaaS monetization platform for publishers to maximize revenue, reduce costs and deliver better ad experiences.The Polymorph platform offers end-to-end ad serving stack, yield optimization tools, APIs, access to demand on server-side and self-serve workflows. Modern enterprises who want to monetize with advertising choose our customizable and developer friendly platform as it aligns with their needs/strategies. The company was founded in 2013 and is based in San Francisco, California.

Glaukos Corporation

Series F in 2013
Glaukos Corporation is an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures designed to transform the treatment of glaucoma, one of the world’s leading causes of blindness. They have pioneered Micro-Invasive Glaucoma Surgery, or MIGS, in order to revolutionize the traditional glaucoma treatment and management paradigm. They launched the iStent®, their first MIGS device, in the United States in 2012. They are leveraging their platform technology to build a comprehensive and proprietary portfolio of injectable micro-scale therapies designed to address the complete range of glaucoma disease states and progression. They believe the iStent® is the smallest medical device ever approved by the Food and Drug Administration, or FDA, measuring 1.0 mm long and 0.33 mm wide. In June 2015, they completed an initial public offering and their shares are now traded on the New York Stock Exchange under the ticker symbol “GKOS”. The company was founded in 1998 and is based in San Clemente, California.

ReVision Optics

Series E in 2013
ReVision Optics, Inc. designs, manufactures, and delivers implantable products for the treatment of presbyopia. It offers PRESBYLENS Corneal Inlay, a refractive surgery solution to correct vision lost by the natural aging process called presbyopia. The company serves the ophthalmology professionals. ReVision Optics, Inc. was formerly known as IntraLens Vision, Inc. and changed its name to ReVision Optics, Inc. in 2005. The company was founded in 1996 and is based in Lake Forest, California.

Ciena Corporation

Series C in 1995
Ciena is the network specialist. They collaborate with customers worldwide to unlock the strategic potential of their networks and fundamentally change the way they perform and compete. With focused innovation, Ciena brings together the reliability and capacity of optical networking with the flexibility and economics of Ethernet, unified by a software suite that delivers the industry's leading network automation. They routinely post recent news, financial results and other important announcements and information about Ciena on their website.

Scale Eight

Series B in 2000
Scale Eight is an internet company. It offers virtually limitless storage capacity, allowing companies to grow their online offerings. Scale Eight delivers file storage solutions technology through its global storage service and in a family of network-attached storage products. Scale Eight was founded by Josh Coates and is located in San Francisco, California.

Pivot3

Series D in 2010
Global Hyper-Converged Infrastructure

Convey Computer

Series B in 2009
Convey Computer offers a hybrid core computer for the oil and gas, financial analytics, and bioinformatics markets. The comp[any delivers decades of experience and intellectual assets to performance problem-solving. Its executive and design teams all come from successful backgrounds of building computer companies, most notably Convex Computer Corporation and Hewlett-Packard.

Avedro

Venture Round in 2017
Medical device and pharmaceutical company advancing the science and technology of corneal cross-linking

ARCA biopharma

Series B in 2007
ARCA biopharma, Inc. is a Colorado-based biopharmaceutical company developing genetically-targeted therapies for cardiovascular diseases. ARCA’s principal focus is to develop personalized therapies for the treatment of cardiovascular disease through the use of genetics. The Company’s business focus combines expertise in cardiovascular pathophysiology, molecular genetics and clinical development.

OmniPV

Venture Round in 2008
OmniPV develops and produces solar energy solutions for its clients. It was founded in 2000. OmniPV is headquartered in Belmont, California.

Optimizely, Inc.

Series A in 2013
Optimizely is provides customer experience optimization, allowing businesses to dramatically drive up the value of their digital products, commerce, and campaigns through its best in class experimentation software platform. By replacing digital guesswork with evidence-based results, Optimizely enables product and marketing professionals to accelerate innovation, lower the risk of new features, and drive up the return on investment from digital by up to 10X. Over 26 of the Fortune 100 companies choose Optimizely to power their global digital experiences. Optimizely’s impressive customer list includes eBay, FOX, IBM, The New York Times, and many more global enterprises. Optimizely was founded in 2009 and is headquartered in San Francisco, California.

Pivot3

Series G in 2015
Global Hyper-Converged Infrastructure

Sierra Logic

Series C in 2003
Sierra Logic was founded in 2001 by four veterans of storage silicon products, all formerly of HP and Agilent Technologies. Sierra Logic is currently operating in "quiet mode", and specific product plans are being shared with customers under NDA.

USGI Medical

Series C in 2006
USGI Medical, Inc. engages in the development of technologies that enable surgeons and gastroenterologists to perform procedures through the body's natural passageways. The company offers specialized tools to perform minimally invasive procedures through a patient's mouth or other natural orifices. It offers its products obesity, natural orifice translumenal endoscopic surgery, and gastroesophageal reflux disease. The company was incorporated in 2001 and is based in San Clemente, California.

Osito

Seed Round in 2013
Osito (formerly Sherpa) is a predictive intelligence iOS app and platform that gets you the information you need so you can stay one step ahead every day. By combining the power of location data with updates from your calendar, email and daily routine, Osito manages the details of everything from work travel to your weekly meetings and commute. Unlike other applications, services or even personal assistants out there, Osito is proactive, not reactive – and location, not calendar based. It learns what you need to know based on the information you provide, including your location as well as your day-to-day routine – making every day just a little easier. Osito was part of **[AngelPad](http://angelpad.org) #4** in 2012.
Applied Genetics Technologies Corporation (AGTC) is developing therapies designed to transform the lives of patients with severe diseases, offering hope to patients with unmet medical needs. With a highly specialized team of physicians and researchers, They use cutting-edge techniques to develop treatments for patients that have diseases caused by broken genes. They use gene therapy, which replaces those broken genes with normal functional genes, allowing a patient’s own body to produce proteins to treat their illness. A single injection provides long-lasting treatment, leading to a better quality of life for patients worldwide.
The mission of Integrated Diagnostics is to leverage powerful emerging technologies in the development of diagnostic products that enable physicians and patients to manage complex and important diseases such as cancer, diabetes and Alzheimer's through blood tests that can monitor tens to hundreds of disease markers simultaneously. The company plans to develop a pipeline of game-changing diagnostic products that enable the diagnosis and prognosis of a variety of diseases. The company is based on the concept of a systems view of disease where pathophysiology arises from disease-perturbed networks of proteins, genes and other molecules.

Pivot3

Series E in 2014
Global Hyper-Converged Infrastructure

Stellar Loyalty Inc.

Venture Round in 2016
Stellar Loyalty is the first application provider to deliver breakthrough cloud-based, big data customer loyalty, and engagement solutions. The company's mission is to bring delight and value to every consumer experience by enabling brands to instantly recognize, engage, and reward their loyal customers across the network of digital, physical, and human interactions. Founded in 2014 and funded by InterWest Partners and TDF Ventures, Stellar Loyalty is privately held with offices in Foster City, California, Dublin, Ireland, and Manila, Philippines.

Avera Pharmaceutical

Series A in 2002
Avera Pharmaceuticals is a specialty pharmaceutical company that acquires, develops, and commercializes pharmaceutical compounds. The company develops gantacurium, a neuromuscular blocking agent for rapid and routine endotracheal intubation and skeletal muscle relaxation during surgery; AV810 for the treatment of overactive bladder and irritable bowel syndrome; and AV965 to treat cognitive impairment associated with schizophrenia and Alzheimer’s dementia. The company was founded in 2002 and is headquartered in San Diego, California.
The mission of Integrated Diagnostics is to leverage powerful emerging technologies in the development of diagnostic products that enable physicians and patients to manage complex and important diseases such as cancer, diabetes and Alzheimer's through blood tests that can monitor tens to hundreds of disease markers simultaneously. The company plans to develop a pipeline of game-changing diagnostic products that enable the diagnosis and prognosis of a variety of diseases. The company is based on the concept of a systems view of disease where pathophysiology arises from disease-perturbed networks of proteins, genes and other molecules.

Convey Computer

Series A in 2007
Convey Computer offers a hybrid core computer for the oil and gas, financial analytics, and bioinformatics markets. The comp[any delivers decades of experience and intellectual assets to performance problem-solving. Its executive and design teams all come from successful backgrounds of building computer companies, most notably Convex Computer Corporation and Hewlett-Packard.

Amplimmune

Series A in 2006
Amplimmune is a product driven company that is developing immune-based biologics to treat patients in the areas of cancer, autoimmunity, transplantation and infectious diseases. Amplimmune's scientific founders from Johns Hopkins University have identified several key immunological ligands and receptors. These immunological checkpoint and co-stimulatory molecules are the basis for developing a new class of biological treatments which modulate critical mechanisms in the body's immune system with the aim of bettering the lives of patients suffering from aberrant immunological conditions.

Vidora

Seed Round in 2017
Vidora’s mission is to enhance the performance of Marketing and Product teams with No-Code Machine Learning. Our Machine Learning Platform, Cortex, allows teams to use predictions to continually optimize conversions and engagement, while providing end-to-end automation, allowing teams to create hundreds of predictions without the risk and cost of building in house. The largest global brands like Walmart, News Corp, and Discovery, leverage Cortex to intelligently learn from continuous streams of raw data to drive higher performance and automation across the enterprise.

NeuroPace

Venture Round in 2013
NeuroPace, Inc. designs, develops, manufactures, and markets implantable devices for the treatment of neurological disorders with responsive stimulation. It offers RNS System, a medical device that monitors and responds to brain activity. The company’s RNS System consists of a small implantable neuro stimulator that is connected to leads that are placed in up to two seizure onset areas. NeuroPace, Inc. was founded in 1997 and is based in Mountain View, California.

Splice Machine, Inc.

Venture Round in 2019
Splice Machine is a data platform that offers offline, and batch analysis, and powers intelligent applications for operational workflows. Splice Machine is disrupting the $30 billion traditional database world with the open-source dual-engine RDBMS for mixed operational and analytical workloads, powered by Apache Hadoop and Apache Spark. The Splice Machine RDBMS executes operational workloads on Apache HBase® and analytical workloads on Apache Spark. Splice Machine makes it easy to develop and create modern, real-time, scalable applications, or to offload operational and analytical workloads from expensive Oracle, Teradata, and Netezza systems. Typical use cases are ETL, operational reporting, or real-time applications.

KAI Pharmaceuticals

Series A in 2003
KAI Pharmaceuticals is a drug discovery and development company with multiple, novel clinical-stage programs in the areas of cardiovascular disease, kidney disease and pain. KAI lead product candidate, KAI-9803, is currently in a Phase 2b study (PROTECTION AMI) designed to assess the effect of KAI-9803 on reducing myocardial injury in heart attack patients. KAI second core program, KAI-4169 for the treatment of secondary hyperparathyroidism (SHPT) in kidney disease patients, is expected to enter human clinical trials in 2010. KAI also has an ongoing pain program, KAI-1678, which is currently in Phase 2a testing.

ReVision Optics

Series D in 2010
ReVision Optics, Inc. designs, manufactures, and delivers implantable products for the treatment of presbyopia. It offers PRESBYLENS Corneal Inlay, a refractive surgery solution to correct vision lost by the natural aging process called presbyopia. The company serves the ophthalmology professionals. ReVision Optics, Inc. was formerly known as IntraLens Vision, Inc. and changed its name to ReVision Optics, Inc. in 2005. The company was founded in 1996 and is based in Lake Forest, California.

Bloomspot

Series B in 2011
Bloomspot provides exclusive offers for renowned local restaurants, spas, salons, weekend getaways, events, and international resorts. A highly targeted member base, expertly sourced partners, and individually designed promotions ensures member satisfaction and profitability for merchant partners. Bloomspot has featured the highest-rated experiences including 100 Zagat-rated restaurants and AAA Four Diamond hotels in some of the largest U.S. markets.

Flotype

Seed Round in 2012
Flotype Inc. is a venture-backed company building a suite of enterprise technology for real-time messaging. Flotype takes a unique approach by building developer-friendly technologies focused on ease-of-use and simplicity, while still exceeding enterprise-grade performance expectations. Flotype licenses enterprise-grade middleware, Bridge, to customers ranging from social web and software enterprises to financial and fleet management groups. Other offerings include NowJS, a free, open-source framework, for developers seeking real-time interactivity on Node.js and JavaScript browsers. NowCluster is available for companies seeking scalability and reliability for NowJS applications. Established in 2010 and based in Berkeley, California, Flotype is venture-backed by Andreessen Horowitz, Ignition Partners, InterWest Partners, and Salesforce.com.

Microchips Biotech, Inc.

Venture Round in 2010
Microchips Biotech, Inc. is dedicated to improving the lives of patients by revolutionizing drug delivery. Our proprietary microchip-based implant can store and release precise doses of drugs over months and years. The implant, which is placed under the skin by a trained physician during a simple office procedure using local anesthesia, can be wirelessly activated or deactivated by a physician or patient, without requiring removal. In addition, physicians can wirelessly modify the frequency or dose of the drug to meet the individual needs of each patient.

The RealReal, Inc.

Series B in 2013
The RealReal, Inc. operates an online marketplace for consigned luxury goods. It offers various resale product categories, including women’s, men’s, kids’, jewelry, and watches, as well as home and art products. The company was founded in 2011 and is headquartered in San Francisco, California.

Autonomic Technologies

Series B in 2009
Autonomic Technologies, Inc. is a medical device company that focuses on the development and commercialization of therapies for the treatment of autonomic disorders, particularly severe headache. It develops ATI Neurostimulation System, a device that delivers low-level energy directly to the area of the SPG for the treatment of chronic cluster headache. The company was founded in 2007 and is based in Mountain View, California with additional offices in Germany and Switzerland.

Autonomic Technologies

Series D in 2015
Autonomic Technologies, Inc. is a medical device company that focuses on the development and commercialization of therapies for the treatment of autonomic disorders, particularly severe headache. It develops ATI Neurostimulation System, a device that delivers low-level energy directly to the area of the SPG for the treatment of chronic cluster headache. The company was founded in 2007 and is based in Mountain View, California with additional offices in Germany and Switzerland.

Stellar Loyalty Inc.

Series A in 2016
Stellar Loyalty is the first application provider to deliver breakthrough cloud-based, big data customer loyalty, and engagement solutions. The company's mission is to bring delight and value to every consumer experience by enabling brands to instantly recognize, engage, and reward their loyal customers across the network of digital, physical, and human interactions. Founded in 2014 and funded by InterWest Partners and TDF Ventures, Stellar Loyalty is privately held with offices in Foster City, California, Dublin, Ireland, and Manila, Philippines.

Anesiva

Series B in 2001
Anesiva, Inc., a biopharmaceutical company, engages in the development and commercialization of novel therapeutic treatments for pain management worldwide. Its lead product candidate includes Adlea, which completed multiple Phase II and Phase III trials for post-surgical, musculoskeletal, and neuropathic pain. The company was formerly known as AlgoRx Pharmaceuticals, Inc., it changed its name to Anesiva, Inc. in 2006. Anesiva, Inc. was founded in 1999 and is headquartered in South San Francisco, California. On January 15, 2010, Anesiva, Inc. filed a voluntary petition for liquidation under Chapter 7 in the U.S. Bankruptcy Court for the Northern District of California. On June 10, 2014 filed for Chapter 7 bankruptcy.

Ophthonix

Series D in 2006
Ophthonix, Inc. manufactures and markets high resolution spectacle lenses for vision assessment and correction applications. It offers its high resolution lenses for single vision spectacle lenses for the correction of myopia, hyperopia, and mild astigmatism; and progressive addition spectacle lenses. The company sells its products through practitioners in the United States and European countries. Ophthonix, Inc. was founded in 2000 and is based in Vista, California.

Restoration Robotics

Venture Round in 2016
Restoration Robotics is a privately held medical device company, is dedicated to revolutionizing the field of hair transplantation by developing and commercializing a state-of-the-art image-guided system (ARTAS™ System) that enables follicular unit extraction.
RedShiftBio provides an infrared technology with advanced data analytics to facilitate better, faster decision making in biopharmaceutical development from discovery to market via the direct measurement of previously undetectable change in protein structural attributes critical to drug product efficacy and quality. It has developed a Microfluidic Modulation Spectroscopy (MMS) platform in response to a customer’s request for a better solution, and rather than repurpose outdated tools and methods designed originally for other applications. They started a new and developed MMS from the ground up specifically with the protein scientist in mind. The company was founded in 2005 and is headquartered in Burlington, Massachusetts.

Tizona Therapeutics, Inc.

Series B in 2016
The company is establishing collaborations with its scientific founders “to better understand whether regulatory T cells play a more prominent role in certain tumors,” he added. Although research suggests that Tregs cells play a more prominent role in creating immunosuppression in the microenvironment in some tumor types than others, “quite honestly, the data are lacking. One of the ways we’re going to differentiate the company is to understand that relationship better.

LongBoard

Series D in 2005
LongBoard, Inc. provides software solutions to enable the telecommunications carriers and service providers to deliver converged multimedia services. Its products include MediaRoam that provides telecommunications carriers with the ability to deliver differentiated Initiation Protocol Multimedia Subsystem enabled multimedia services across fixed and mobile networks; LongBoard Multimedia Application Platform, which provides a carrier-class software infrastructure for integrating IP-based communications; and OnePhone, a personal mobility application that automatically and transparently switches calls between cellular and WiFi networks. LongBoard, Inc. was formerly known as Persona Software, Inc. and it changed its name to LongBoard, Inc. in February 2006. The company was founded in 1999 and is based in Santa Clara, California with sales offices in London, the United Kingdom and Tokyo, Japan.

Platform Solutions

Series A in 2004
Platform Solutions, Inc. develops Open Mainframe computers compatible with a set of datacenter environments and operating systems. It offers Open Mainframe servers, Open Systems servers, and NEC D-Series storage arrays. The company's System64 product line consolidates z/OS, Windows, and Linux operating system in one secure and reliable operating environment based on Intel Itanium 2 processor technology. Platform Solutions has a strategic partnership with T3 Technologies. The company was founded in 1999 and is based in Sunnyvale, California. As of June 30, 2008, Platform Solutions, Inc. operates as a subsidiary of International Business Machines Corp.

Neuronetics

Series D in 2009
Neuronetics is focused on developing non-invasive therapies for psychiatric and neurological disorders using MRI-strength magnetic field pulses. They are the first and only company to have a non-systemic and non-invasive depression treatment cleared by the FDA for patients who have not benefited from prior antidepressant treatment. The company was founded in 2003 and is based in Malvern, Pennsylvania.

Tapjoy

Series A in 2007
Tapjoy’s Maximum Impact Platform™ provides mobile engagement and monetization services for leading advertisers and app developers. Advertisers rely on Tapjoy’s diverse suite of rewarded Interplay™ ads including video and rich media to impact performance. Developers utilize our technology and mobile expertise to acquire and monetize users. The Tapjoy SDK is currently embedded in over 15,000 mobile apps, reaching 520 million monthly active users. A 2016 comScore™ study confirmed Tapjoy Interplay® ads deliver an unprecedented 3x lift across all brand metrics. The company works with Fortune 500 brands and the Top 200 grossing app developers. Founded in 2007, Tapjoy is a global organization with more than a dozen offices worldwide and is headquartered in San Francisco.

Aria Systems, Inc.

Series C in 2011
Proven by the world's most demanding enterprises, including AAA NCNU, Constant Contact, Falck, Hootsuite, Pitney Bowes, Audi, Adobe, Telekom Denmark, Philips, Roku, and VMware, Aria helps enterprises grow their recurring revenue businesses. Aria helps clients take advantage of each customer-driven event − known as revenue moments − with agile billing, active customer engagement, and the rapid development of new products and services. With Aria's end-to-end active monetization platform, global brands can get to market faster with a wider variety of products and services, while maximizing customer satisfaction, retention, and lifetime value.

Avaak

Series B in 2010
Avaak is a provider of wireless video networking technology. Their applications are used in a variety of environments, from businesses to the military. The company is venture backed, and initially developed its wire-free video networking technology with sponsorship from DARPA and the Office of Naval Research (ONR).

Platform Solutions

Series C in 2007
Platform Solutions, Inc. develops Open Mainframe computers compatible with a set of datacenter environments and operating systems. It offers Open Mainframe servers, Open Systems servers, and NEC D-Series storage arrays. The company's System64 product line consolidates z/OS, Windows, and Linux operating system in one secure and reliable operating environment based on Intel Itanium 2 processor technology. Platform Solutions has a strategic partnership with T3 Technologies. The company was founded in 1999 and is based in Sunnyvale, California. As of June 30, 2008, Platform Solutions, Inc. operates as a subsidiary of International Business Machines Corp.

Xirrus

Series D in 2009
Xirrus, Inc. manufactures and markets wireless networking products. The company offers indoor enclosures, snap-on covers, manufacturing rated enclosures, I-beam mounting kits, and outdoor enclosures; and products for improving security and minimizing the risk in deploying 802.11n wireless networks. It also provides Wi-Fi Array, a wireless networking device that integrates radios, high-gain directional antenna systems, multi-gigabit switches, controllers, firewalls, threat sensors, and embedded spectrum analyzers. In addition, the company offers power over gigabit Ethernet (PoGE) products; and a Management System, which offers a platform for the central management of a Wi-Fi Array network. It serves general enterprise, higher education, K-12 education, conference centers, hospitality, and manufacturing markets. The company was founded in 2004 and is headquartered in Thousand Oaks, California.

Benvenue Medical

Series F in 2016
Benvenue Medical, Inc. is developing innovative, minimally invasive surgical solutions to treat spinal disorders. The company is privately held and funded by CRG Partners.

Obalon Therapeutics, Inc.

Series E in 2016
Obalon is an engineering-driven medical technology company with a singular focus on innovative, high-quality gastric balloon technology. Located in San Diego, California, the technical team at Obalon has a long history of working closely with leading clinicians to develop innovative medical products that revolutionize the treatment of chronic disease. As a company, they believe in the fundamental value of imagination and invention, combined with rigorous testing and analysis, to ensure the highest levels of safety and performance. The result is a user-focused approach that deploys the power of advanced technological thinking to support clinical treatment objectives. It was founded in 2008.

Stellar Loyalty Inc.

Series A in 2014
Stellar Loyalty is the first application provider to deliver breakthrough cloud-based, big data customer loyalty, and engagement solutions. The company's mission is to bring delight and value to every consumer experience by enabling brands to instantly recognize, engage, and reward their loyal customers across the network of digital, physical, and human interactions. Founded in 2014 and funded by InterWest Partners and TDF Ventures, Stellar Loyalty is privately held with offices in Foster City, California, Dublin, Ireland, and Manila, Philippines.

Carbylan Therapeutics

Venture Round in 2013
Carbylan Therapeutics was founded in 2004 with worldwide headquarters currently located in Palo Alto, California. They are a clinical-stage specialty pharmaceutical company focused on the development and commercialization of proprietary combination therapies. Our vision is to deliver best-in-class therapies to large growing markets where there is a clear unmet clinical need.

PMV Pharmaceutcals

Series C in 2019
PMV Pharma is developing first-in-class p53 and p53 pathway modulators for the treatment of cancer. Bringing together leaders in the field to utilize over three decades of p53 biology, PMV Pharma combines unique biological understanding with pharmaceutical development focus.

Sera Prognostics

Series B in 2015
Sera Prognostics, Inc., a biotechnology company, develops diagnostic tests for the early prediction of a woman’s individualized risk of premature birth, preeclampsia, and other pregnancy complications. It focuses on addressing the economic and healthcare burden that premature birth places on infants, their families, and society. Sera Prognostics, Inc. was founded in 2008 and is based in Salt Lake City, Utah.

Braze

Series B in 2014
Braze is a comprehensive customer engagement platform that powers relevant and memorable experiences between consumers and the brands they love. Context underpins every Braze interaction, helping brands foster human connection with consumers through interactive conversations across channels that deliver value quickly and continuously. The company was named a Leader in the 2019 Gartner Magic Quadrant for Mobile Marketing Platforms and was recognized as one of Inc Magazine's 2019 Best Workplaces. Braze is headquartered in New York with offices in Chicago, London, San Francisco, and Singapore. Learn more at braze.com.

Ciena Corporation

Series B in 1994
Ciena is the network specialist. They collaborate with customers worldwide to unlock the strategic potential of their networks and fundamentally change the way they perform and compete. With focused innovation, Ciena brings together the reliability and capacity of optical networking with the flexibility and economics of Ethernet, unified by a software suite that delivers the industry's leading network automation. They routinely post recent news, financial results and other important announcements and information about Ciena on their website.

Arcion Therapeutics

Series A in 2007
Arcion Therapeutics, Inc., a biotechnology company, focuses on the development of treatments for severe pain. It offers a pipeline of products for the treatment of painful diabetic neuropathy, post-herpetic neuralgia, and various forms of moderate and severe pain. The company was incorporated in 2007 and is based in Baltimore, Maryland.

Famous.co

Seed Round in 2011
When a company can revolutionize the ease of creation, storage, and management of something that has become integral to business and culture, that company can build a billion dollar empire. Microsoft did it with Word, which revolutionized documents; it did it with Excel for spreadsheets; and it did it again with Powerpoint for presentations. Together with the Microsoft Operating System called Windows, Microsoft built an empire on a bundled suite now called Microsoft Office 365. Since Microsoft, the world has moved online, has moved to mobile, and the things that are now integral to business and culture have shifted. Today, if you created a pie chart of the utilities that are essential to business and society it would consist of mobile apps, videos, ads, articles, and online presentations. The problem for these modern utilities is they suffer from the same problems that documents, spreadsheets, and presentations did at the dawn of Microsoft’s empire. They are time consuming, they are costly to create, and there exists to no unified, integrated way of managing and storing them. What Famous intends to do is revolutionize creation, storage, and management of these new Internet utilities. Together with our platform, called Famous Studio, we will offer powerful creation tools for Instant Apps, Instant Ads, Instant Videos, Instant Articles, and Instant Presentations that reduce creation time from months to minutes. To manage and store assets created with our Famous Studio, we offer Famous Publisher to manage them, Famous Analytics to measure their performance, and Famous Drive to store every beautiful creation.

FetchRev

Venture Round in 2012
FetchRev is a company that provides highly personalized offers and promotions delivered at the right time and place. Most local businesses lack the time and expertise to do this in an effective, quantifiable, and affordable manner without being ripped off. Consequently, they devote thousands of dollars to generic marketing strategies and tools that yield minimal results, if any at all. FetchRev allows businesses to drive more traffic to entertainment, health and beauty, food and beverage, and other local businesses.

Brecis Communications

Series B in 2001
BRECIS Communications, a communications company focused on leading-edge, broadband multi-service network processor architectures.

Metro Optix

Series A in 2000
Metro-Optix develops hardware for telecommunications companies that want to transition from circuit-based services to cell- and packet-based services. The hardware essentially reduces the number of hardware boxes needed, such as routers, which the networks feed into.

Indi Molecular

Seed Round in 2013
Indi Molecular, Inc., a life sciences company, develops a synthetic class of diagnostic and therapeutic agents with antibody-like properties. It offers protein catalyzed capture as a small molecule replacement for antibodies in vivo imaging, therapeutics, in vitro diagnostics, and biological tools. The company was founded in 2013 and is based in Culver City, California.

Aria Systems, Inc.

Series E in 2016
Proven by the world's most demanding enterprises, including AAA NCNU, Constant Contact, Falck, Hootsuite, Pitney Bowes, Audi, Adobe, Telekom Denmark, Philips, Roku, and VMware, Aria helps enterprises grow their recurring revenue businesses. Aria helps clients take advantage of each customer-driven event − known as revenue moments − with agile billing, active customer engagement, and the rapid development of new products and services. With Aria's end-to-end active monetization platform, global brands can get to market faster with a wider variety of products and services, while maximizing customer satisfaction, retention, and lifetime value.

Doximity

Series C in 2014
Founded in 2011, Doximity connects physicians and clinicians to make them more successful and productive. It is the largest professional medical network with over 70 percent of all U.S. physicians as members. The network enables medical professionals to communicate with colleagues and patients, and to share their perspectives on the latest health care trends and research. Doximity is based in San Francisco and was created by the founders of Epocrates and Rock Health. To learn more, visit www.doximity.com

Cidara Therapeutics

Series A in 2014
Cidara Therapeutics is a biotechnology company that specializes in the fields of healthcare and therapeutics. The company focuses on developing innovative therapies to treat life-threatening illnesses exacerbated by deficiencies of the human immune system. Cidara Therapeutics was founded in 2012 and headquartered in San Diego, California.
Advanced Micro-Fabrication Equipment Inc. (中微半导体设备(上海)有限公司) is a Chinese global microfabrication equipment company serving customers in the semiconductor industry and relevant high-tech sectors. The company is a specialized supplier of key equipment for the production and development of micron-sized and nanoscale VLSI for the semiconductor industry in China and Asia. The company is focused on chemical vapor deposition and plasma etching products.

Nanostim

Venture Round in 2013
Nanostim is an early-stage medical device company working to prevent more than 100,000 annual complications related to pacemakers. Nanostim has assembled a world-class team of experienced medical device engineers to help bring this exciting technology to the marketplace.

Archus Orthopedics

Series C in 2006
Archus Orthopedics is focused on the development of implants to treat a variety of spine disorders that result from degenerative changes in the facet joints. Archus Orthopedics offers Total Facet Arthroplasty System, a spinal implant that is designed for patients suffering from lumbar spinal stenosis. Archus Orthopedics was acquired by Facet Solutions in November 2009. Archus Orthopedics was founded in 2001 and is based in Redmond, Washington.

Biba Systems, Inc.

Series B in 2013
Biba Systems, Inc. offers a mobile-first business application that delivers conference calls and messaging services for businesses. It offers Biba, an integrated application that allows users to work with their teams; helps people get in touch instantly; and works across companies and devices. The company was founded in 2011 and is based in San Francisco, California. As of December 31, 2015, Biba Systems, Inc. operates as a subsidiary of Amazon.com, Inc..

Swell

Series A in 2013
Swell is a podcast-like application where listeners also participate in the conversation. It lets users share ideas, ask questions, tell stories and jokes, discuss experiences, provide perspective, and much more. Its listeners can also reply with their own audio posts creating a conversation that is social, fun, and engaging.

CVRx, Inc.

Series E in 2008
CVRx is a medical device company that develops implantable technology for the treatment of high blood pressure. Its products include Rheos implantable pulse generator that provides control and delivery of the activation energy; and Rheos carotid sinus leads, which conducts activation energy from the Rheos implantable pulse generator to the left and right carotid arteries. The company also offers a Rheos programmer system that communicates with the Rheos pulse generator. CVRx was founded in 2001 and is based in Minneapolis, Minnesota.
InVisage Technologies Inc., a fabless semiconductor company, produces quantum dot-based image sensors. The company's product enables the high resolution images from handheld devices, such as camera phones and PDAs. Its products are used in security and surveillance, automotive imaging, military, and medical imaging applications, as well as mobile phone cameras, Webcams, and digital still cameras. The company was incorporated in 2005 and is based in Menlo Park, California.

Autonomic Technologies

Series D in 2015
Autonomic Technologies, Inc. is a medical device company that focuses on the development and commercialization of therapies for the treatment of autonomic disorders, particularly severe headache. It develops ATI Neurostimulation System, a device that delivers low-level energy directly to the area of the SPG for the treatment of chronic cluster headache. The company was founded in 2007 and is based in Mountain View, California with additional offices in Germany and Switzerland.

Salmedix Inc

Series A in 2001
Salmedix is an oncology drug development company with a commercial focus on the treatment of hematologic malignancies, or blood cancers. Its primary product, SDX-105, is marketed by healthcare professionals in Germany for the treatment of several types of blood cancers. Salmedix conducts Phase II clinical trials for SDX-105 in the U.S. and Canada. Its other clinical-stage product candidates, SDX-101 and SDX-102, each with significant prior human clinical experience, are also in Phase II development. Founded in 2000 by David Kabakoff, Salmedix is headquartered in San Diego, California.

Restoration Robotics

Series B in 2007
Restoration Robotics is a privately held medical device company, is dedicated to revolutionizing the field of hair transplantation by developing and commercializing a state-of-the-art image-guided system (ARTAS™ System) that enables follicular unit extraction.

Gynesonics

Venture Round in 2015
Gynesonics, Inc. designs and develops minimally invasive solutions for symptomatic uterine fibroids in women. The company offers Sonography-Guided Transcervical Fibroid Ablation (Sonata) System(The Sonata System) for the transcervical treatment of symptomatic uterine fibroids under intrauterine sonography guidance serving customers in the European Union. Gynesonics, Inc. was founded in 2005 and is based in Redwood City, California with an additional location in Beuningen, the Netherlands.

Dynavax Technologies

Series D in 2002
Dynavax Technologies Corporation is a clinical-stage biopharmaceutical company committed to discovering and developing novel products to prevent and treat infectious diseases.

Novus Therapeutics, Inc.

Series B in 2006
Novus Therapeutics is a pharmaceutical company focusing on the acquisition, development, and commercialization of ear, nose, and throat (ENT) products. The company has two technologies, each of which has the potential to be developed for multiple ENT indications. It was founded in 2004 and headquartered in Irvine, California.

NewsCred

Series C in 2014

Knotch

Venture Round in 2015
Knotch, Inc. an independent provider of real-time intelligence on digital marketing. It offers Knotch intelligence suite for brands and allows marketers to have a real-time and a comparative view of metrics, benchmarks, and insights. The company was incorporated in 2012 and is based in San Francisco, California.

Flurry, Inc.

Venture Round in 2013
Flurry is an application that provides analytics for businesses to monitor the trends and habits of mobile users across multiple mobile applications. Flurry’s mobile analytics solution enables businesses to understand how consumers interact with their mobile applications. Over 125,000 companies use Flurry’s analytics platform in more than 400,000 applications to measure audience reach, engagement, retention, conversions, revenue, and more. The service is completely free, takes just five minutes for basic integration, and is continuously updated with the industry's advanced features. Flurry Analytics is available for iOS, Android, Windows Phone, HTML5, hybrid apps, mobile/web, Blackberry, and JavaME.

Crowdpac, Inc.

Series A in 2016
Crowdpac is the first crowdfunding platform designed for politics helping candidates, organizations, and ordinary citizens fund the change they want to see. They use the best technology and objective data to boost political participation, helping citizens to vote, by understanding the candidates on their ballot; to fund political change through crowdfunding tools, and helping anyone run for office by raising money and mobilizing support independent of big donors and special interests. It was founded is 2013 and is headquartered in San Francisco, California.
Advanced Micro-Fabrication Equipment Inc. (中微半导体设备(上海)有限公司) is a Chinese global microfabrication equipment company serving customers in the semiconductor industry and relevant high-tech sectors. The company is a specialized supplier of key equipment for the production and development of micron-sized and nanoscale VLSI for the semiconductor industry in China and Asia. The company is focused on chemical vapor deposition and plasma etching products.

USGI Medical

Series B in 2003
USGI Medical, Inc. engages in the development of technologies that enable surgeons and gastroenterologists to perform procedures through the body's natural passageways. The company offers specialized tools to perform minimally invasive procedures through a patient's mouth or other natural orifices. It offers its products obesity, natural orifice translumenal endoscopic surgery, and gastroesophageal reflux disease. The company was incorporated in 2001 and is based in San Clemente, California.
Advanced Micro-Fabrication Equipment Inc. (中微半导体设备(上海)有限公司) is a Chinese global microfabrication equipment company serving customers in the semiconductor industry and relevant high-tech sectors. The company is a specialized supplier of key equipment for the production and development of micron-sized and nanoscale VLSI for the semiconductor industry in China and Asia. The company is focused on chemical vapor deposition and plasma etching products.

Metro Optix

Series B in 2000
Metro-Optix develops hardware for telecommunications companies that want to transition from circuit-based services to cell- and packet-based services. The hardware essentially reduces the number of hardware boxes needed, such as routers, which the networks feed into.

Virsto Software

Series B in 2011
Virsto was founded in late 2007 by a team of storage and virtualization experts who saw that the old ways of doing storage were not working in the virtual server era. We believe we are building a visionary storage software platform that will fundamentally transform the data center – decoupling storage from the physical world once and for all to save organizations time and money. Virsto's solutions address the growing need for cost-effective and efficient storage for virtual servers and desktops. Companies around the world use Virsto to achieve increases in performance, reduce storage capital and operating costs, and streamline provisioning and data management for virtual computing.

Venturi Wireless, Inc.

Series C in 2005
Provider of 3G mobile optimization solutions. The company offers mobile broadband optimization solutions to wireless carriers and enterprises worldwide. Its carrier-grade solutions are designed to maximize network efficiency and deliver mobile user experience available for both data and multimedia applications.

C9 Inc.

Series A in 2007
C9 delivers predictive sales and marketing applications that increase revenue, generate more precise forecasts and mitigate pipeline risk. By combining data science with products that improve sales and marketing execution, C9 enables leading companies like Yahoo!, Pitney Bowes and Google to drive predictable growth. C9 is located in San Mateo and is backed by the Mayfield Fund, InterWest Partners and Leapfrog Ventures.

Marketo

Series F in 2011
Marketing automation software

Splice Machine, Inc.

Series B in 2014
Splice Machine is a data platform that offers offline, and batch analysis, and powers intelligent applications for operational workflows. Splice Machine is disrupting the $30 billion traditional database world with the open-source dual-engine RDBMS for mixed operational and analytical workloads, powered by Apache Hadoop and Apache Spark. The Splice Machine RDBMS executes operational workloads on Apache HBase® and analytical workloads on Apache Spark. Splice Machine makes it easy to develop and create modern, real-time, scalable applications, or to offload operational and analytical workloads from expensive Oracle, Teradata, and Netezza systems. Typical use cases are ETL, operational reporting, or real-time applications.

Intarcia Therapeutics

Series B in 1999
Intarcia Therapeutics is a biopharmaceutical company that develops therapies for diseases that require long-term chronic treatment. It offers DUROS, a drug delivery platform that stabilizes and delivers therapeutic proteins and peptides. Intarcia Therapeutics' products include OMEGA DUROS, an interferon delivery device for treating Hepatitis C and ITCA 650, a delivery device that provides type 2 diabetes patients with long-term steady state dosing of an incretin mimetic therapy. Additionally, it develops programs for treating obesity. David Franklin, James M. Ahlers, and Thomas Alessi founded BioMedicines in 1997 that became Intarcia Therapeutics in September 2004. Its headquarters is in Hayward in California with an additional office in Mountain View in California.

Eiger BioPharmaceuticals

Series A in 2011
Eiger BioPharmaceuticals is a privately held biotechnology company that develops a novel antiviral therapy for Hepatitis Delta, a life-threatening, Orphan Disease with high unmet medical need and no approved therapy. The company is led by a management team experienced in the development and commercialization of rare disease therapeutics. Its strategy is predicated upon time and cost-efficient drug development, with the goal of delivering safe and effective therapies to patients.

AdsNative

Seed Round in 2014
Polymorph powers the monetization infrastructure for modern enterprises. Polymorph is a white-label SaaS monetization platform for publishers to maximize revenue, reduce costs and deliver better ad experiences.The Polymorph platform offers end-to-end ad serving stack, yield optimization tools, APIs, access to demand on server-side and self-serve workflows. Modern enterprises who want to monetize with advertising choose our customizable and developer friendly platform as it aligns with their needs/strategies. The company was founded in 2013 and is based in San Francisco, California.

Carbylan Therapeutics

Series B in 2007
Carbylan Therapeutics was founded in 2004 with worldwide headquarters currently located in Palo Alto, California. They are a clinical-stage specialty pharmaceutical company focused on the development and commercialization of proprietary combination therapies. Our vision is to deliver best-in-class therapies to large growing markets where there is a clear unmet clinical need.

Fluidigm

Series C in 2001
Fluidigm Corporation develops and distributes systems based on the properties of integrated fluidic circuits to control precisely fluids on a nano volume scale. The company's product line includes the TOPAZ system, which is used for protein crystallization; and the BioMark system, which is used for genetic analysis. Fluidigm Corporation was founded as Mycometrix Corporation in 1999 and was renamed as Fluidigm Corporation in 2001. The company is based in San Francisco, California.

IntraLens Vision

Series C in 2004
ReVision Optics, Inc. designs, manufactures, and delivers implantable products for the treatment of presbyopia. It offers PRESBYLENS Corneal Inlay, a refractive surgery solution to correct vision lost by the natural aging process called presbyopia. The company serves the ophthalmology professionals. ReVision Optics, Inc. was formerly known as IntraLens Vision, Inc. and changed its name to ReVision Optics, Inc. in 2005. The company was founded in 1996 and is based in Lake Forest, California.

Staccato Communications

Series C in 2006
Staccato Communications, Inc. offers ultra wideband wireless enabled devices for the wireless USB, Bluetooth, and Internet protocol connectivity to the personal computing, consumer electronics, and mobile phone industries. Its products include single-chip integrated circuits, device adapter and device module design kits, reference design kits, wireless USB development kits, and streaming services development kits. The company also provides Ripcord Software, which provides a software stack for variety of ultra wide band applications, as well as includes installers, firmware, middleware, drivers, customization tools, and firmware upgrade tools. Staccato Communications’ products are used in various applications, such as printers, camera, mass storage devices, portable media players, wireless docking, wireless projectors, Web cameras, wireless HDTV, wireless speakers, set top boxes, wireless displays, purchasing content, sharing content, and personal servers. Staccato Communications, Inc. was formerly known as Discrete Time Communications, Inc. The company was founded in 2002 and is based in San Diego, California.

Ciena Corporation

Series A in 1994
Ciena is the network specialist. They collaborate with customers worldwide to unlock the strategic potential of their networks and fundamentally change the way they perform and compete. With focused innovation, Ciena brings together the reliability and capacity of optical networking with the flexibility and economics of Ethernet, unified by a software suite that delivers the industry's leading network automation. They routinely post recent news, financial results and other important announcements and information about Ciena on their website.
InVisage Technologies Inc., a fabless semiconductor company, produces quantum dot-based image sensors. The company's product enables the high resolution images from handheld devices, such as camera phones and PDAs. Its products are used in security and surveillance, automotive imaging, military, and medical imaging applications, as well as mobile phone cameras, Webcams, and digital still cameras. The company was incorporated in 2005 and is based in Menlo Park, California.

Salmedix Inc

Series B in 2002
Salmedix is an oncology drug development company with a commercial focus on the treatment of hematologic malignancies, or blood cancers. Its primary product, SDX-105, is marketed by healthcare professionals in Germany for the treatment of several types of blood cancers. Salmedix conducts Phase II clinical trials for SDX-105 in the U.S. and Canada. Its other clinical-stage product candidates, SDX-101 and SDX-102, each with significant prior human clinical experience, are also in Phase II development. Founded in 2000 by David Kabakoff, Salmedix is headquartered in San Diego, California.

Aryaka Networks

Series C in 2012
[Aryaka](http://www.aryaka.com)'s Global SD-WAN provides optimized, software-defined network connectivity and application acceleration to globally distributed enterprises. Aryaka’s services have over 10 million users across more than 4,000 sites. Leading brands such as Skullcandy, Air China, Freescale Semiconductor, and ThoughtWorks, as well as partners such as Microsoft Azure, AWS, Intelisys, and SK Broadband, have all chosen Aryaka for their enterprise-grade networking needs.

Exalt Communications

Series C in 2009
Exalt Communications provides wireless backhaul systems and interconnect solutions. Its solutions include microwave radio systems designed to solve the bottlenecks within the last mile, middle mile, and first mile sections of the network. The company serves service providers, mobile carriers, municipal Wi-Fi mesh networks, and emerging carriers and wireless ISPs, as well as education, healthcare, enterprise, government, public safety and emergency response, and industrial sectors. Exalt Communications was founded in 2004 and is based in Campbell, California

Quantance

Series C in 2011
Quantance is a fabless semiconductor company enabling a major breakthrough in data speed and battery life in mobile devices. Quantance's patented RF technology enables users to transmit more signal power from their mobile devices and data cards, which enhances data performance without adversely impacting battery life or requiring any changes to wireless network infrastructure.

Marketo

Series B in 2008
Marketing automation software

Invuity

Private Equity Round in 2015
Invuity, Inc. develops visualization products for the less invasive surgical field applications. It offers BriteField Port System that provides illumination and visualization during minimally invasive procedures; and BriteField McCulloch retractor, which allows physicians to achieve visualization during surgery while using traditional techniques. Invuity, Inc. was formerly known as Spotlight Surgical Inc. The company was founded in 2004 and is headquartered in San Francisco, California.

Avera Pharmaceutical

Series C in 2004
Avera Pharmaceuticals is a specialty pharmaceutical company that acquires, develops, and commercializes pharmaceutical compounds. The company develops gantacurium, a neuromuscular blocking agent for rapid and routine endotracheal intubation and skeletal muscle relaxation during surgery; AV810 for the treatment of overactive bladder and irritable bowel syndrome; and AV965 to treat cognitive impairment associated with schizophrenia and Alzheimer’s dementia. The company was founded in 2002 and is headquartered in San Diego, California.

AccelChip

Series B in 2003
AccelChip, Inc. provides algorithmic synthesis solutions for digital signal processing (DSP) design. The company develops and markets design tools, integrated verification flows, and parametric intellectual property toolkits that automate the development and implementation of DSP algorithms in field programmable gate-arrays and application-specific integrated circuits. AccelChip, Inc. was formerly known as Mach Design Systems, Inc.

PMV Pharmaceutcals

Series B in 2017
PMV Pharma is developing first-in-class p53 and p53 pathway modulators for the treatment of cancer. Bringing together leaders in the field to utilize over three decades of p53 biology, PMV Pharma combines unique biological understanding with pharmaceutical development focus.

Net32

Venture Round in 2000
According to recent ADA surveys, the average dental practice spends $50,000* a year on dental supplies. Many dentists focus solely on increasing their top line by producing more instead of reducing their overhead, missing out on huge profits. Large retail suppliers take advantage of this by charging more for supplies and paying supply representatives big money that comes from your pocket. Net32 can help a business-conscious dentist like you take control of your bottom line, save money, and make greater profits.

Neuronetics

Series E in 2011
Neuronetics is focused on developing non-invasive therapies for psychiatric and neurological disorders using MRI-strength magnetic field pulses. They are the first and only company to have a non-systemic and non-invasive depression treatment cleared by the FDA for patients who have not benefited from prior antidepressant treatment. The company was founded in 2003 and is based in Malvern, Pennsylvania.

Carwoo

Series A in 2011
Carwoo is an online platform that enables its users to anonymously buy cars from dealers in their local area. Carwoo was launched in 2008 and is based in California.

Satori Pharmaceuticals

Series A in 2009
Satori Pharmaceuticals is a neuroscience company focused on the discovery and development of disease-modifying therapies for Alzheimer's disease, Parkinson's disease and other neurodegenerative disorders.

GAIN Fitness

Angel Round in 2013
GAIN Fitness's web and mobile applications generate personalized training plans based on exercise science, matched to an individual's body, goals, and lifestyle factors, to help regular exercisers optimize fitness and adapt to schedule changes. They motivate exercisers with social tie-ins and game mechanics, and keep things fresh with their custom built database of over 750 exercises. They're partnering with personal trainers and equipment retailers to sell interactive multimedia packs, a la App Store for Fitness.

Paracor Medical

Series D in 2007
Paracor Medical is an innovative medical device company focused on providing unique, technology-driven solutions for the treatment of heart failure. Founded in 1999, Paracor was established to pursue new and innovative ways to treat heart failure (HF) that would not require the patient to undergo open chest surgery. Paracor engineers recognized that a mechanical approach to reducing the workload of a failing, diseased heart muscle could be a new and effective solution.

Ocera Therapeutics

Post in 2013
Ocera is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for patients with acute and chronic liver disease, an area of high unmet medical need. Ocera's HE clinical development efforts include a recently completed Phase 2b clinical trial, STOP-HE, which evaluated the safety and efficacy of intravenously-administered OCR-002 in resolving neurocognitive symptoms of acute HE in hospitalized patients with elevated ammonia. Ocera is preparing to meet with the FDA later this year to review the IV program and discuss potential development paths forward.

Invuity

Series D in 2012
Invuity, Inc. develops visualization products for the less invasive surgical field applications. It offers BriteField Port System that provides illumination and visualization during minimally invasive procedures; and BriteField McCulloch retractor, which allows physicians to achieve visualization during surgery while using traditional techniques. Invuity, Inc. was formerly known as Spotlight Surgical Inc. The company was founded in 2004 and is headquartered in San Francisco, California.

On Demand Therapeutics

Debt Financing in 2010
On Demand Therapeutics, Inc. engages in the development of a multi-reservoir implantable device for laser activated, on demand release of drug therapies to the back of the eye. The company was incorporated in 2008 and is based in Menlo Park, California. On Demand Therapeutics, Inc. is a subsidiary of MicroCHIPS, Inc.
Advanced Micro-Fabrication Equipment Inc. (中微半导体设备(上海)有限公司) is a Chinese global microfabrication equipment company serving customers in the semiconductor industry and relevant high-tech sectors. The company is a specialized supplier of key equipment for the production and development of micron-sized and nanoscale VLSI for the semiconductor industry in China and Asia. The company is focused on chemical vapor deposition and plasma etching products.

InnovICs Wireless

Series B in 2000
InnovICs Wireless is focused on providing advanced baseband signal processing solutions to the emerging 2.5G and 3G cellular markets. The company supplies integrated circuits and licenses semiconductor intellectual property cores that deliver unprecedented improvements in data transmission to the wireless handset.

AkaRx

Series A in 2006
AkaRx, Inc., a biopharmaceutical company, develops therapeutic treatments for unmet medical needs. Its product includes AKR-501, an orally-available small molecule for use in the treatment of thrombocytopenia. The company was founded in 2005 and is headquartered in Paramus, New Jersey.

Xenon Pharmaceuticals

Venture Round in 2001
XENON® is a biopharmaceutical company focused on the development of novel medicines through the application of our proprietary discovery platform, which we refer to as Extreme Genetics. Our product candidates are based on genetic insights derived from our research of families where individuals exhibit severe traits, or phenotypes. We apply our expertise to predict which phenotypes are caused by single-gene defects. By identifying and characterizing the single-gene defects responsible for such severe phenotypes, we gain valuable insights into their function in human biology and their potential as drug targets. Given that these targets are often involved in diseases beyond the rare genetic disorders in which they are first identified, we are developing proprietary product candidates to treat both orphan as well as more prevalent diseases

Intarcia Therapeutics

Series C in 2000
Intarcia Therapeutics is a biopharmaceutical company that develops therapies for diseases that require long-term chronic treatment. It offers DUROS, a drug delivery platform that stabilizes and delivers therapeutic proteins and peptides. Intarcia Therapeutics' products include OMEGA DUROS, an interferon delivery device for treating Hepatitis C and ITCA 650, a delivery device that provides type 2 diabetes patients with long-term steady state dosing of an incretin mimetic therapy. Additionally, it develops programs for treating obesity. David Franklin, James M. Ahlers, and Thomas Alessi founded BioMedicines in 1997 that became Intarcia Therapeutics in September 2004. Its headquarters is in Hayward in California with an additional office in Mountain View in California.

SpectraLinear

Series C in 2009
SpectraLinear, Inc., a fabless mixed signal IC company, designs, develops, manufactures, and markets timing circuits. The company's products include computer clocks, buffers, zero delay buffers, EMI reduction circuits, and systems clocks for the consumer and PC clock applications. Its products enable various electronic applications, such as digital television, high definition digital television, digital still camera, digital movie camera or camcorders, set-top box, multi function printers, laser and inkjet printers, copiers, notebook and desktop computers, servers, and communication systems, as well as automotive, gaming, cash registers, and other industrial applications. The company serves consumer, computer, and communication markets. It has locations in Istanbul, Turkey; Bangalore, India; Taiwan; and Japan. SpectraLinear, Inc. was founded in 2006 and is based in Santa Clara, California.

Obalon Therapeutics, Inc.

Series D in 2015
Obalon is an engineering-driven medical technology company with a singular focus on innovative, high-quality gastric balloon technology. Located in San Diego, California, the technical team at Obalon has a long history of working closely with leading clinicians to develop innovative medical products that revolutionize the treatment of chronic disease. As a company, they believe in the fundamental value of imagination and invention, combined with rigorous testing and analysis, to ensure the highest levels of safety and performance. The result is a user-focused approach that deploys the power of advanced technological thinking to support clinical treatment objectives. It was founded in 2008.

MacroGenics

Series D in 2008
MacroGenics, Inc., a biotechnology company, focuses on the development, manufacture, and commercialization of immunotherapeutics for autoimmune disorders, cancer, and infectious diseases. The company is developing immune-based products, including monoclonal antibodies; and vaccines to prevent infections in healthy individuals. The company's Fc engineering technology enables to improve antibody functions to eliminate cancer cells. It is also developing products around the Dual Activating ReTargeting technology. The company was founded in 2000 and is headquartered in Rockville, Maryland.

Anesiva

Series C in 2002
Anesiva, Inc., a biopharmaceutical company, engages in the development and commercialization of novel therapeutic treatments for pain management worldwide. Its lead product candidate includes Adlea, which completed multiple Phase II and Phase III trials for post-surgical, musculoskeletal, and neuropathic pain. The company was formerly known as AlgoRx Pharmaceuticals, Inc., it changed its name to Anesiva, Inc. in 2006. Anesiva, Inc. was founded in 1999 and is headquartered in South San Francisco, California. On January 15, 2010, Anesiva, Inc. filed a voluntary petition for liquidation under Chapter 7 in the U.S. Bankruptcy Court for the Northern District of California. On June 10, 2014 filed for Chapter 7 bankruptcy.

Xirrus

Series E in 2012
Xirrus, Inc. manufactures and markets wireless networking products. The company offers indoor enclosures, snap-on covers, manufacturing rated enclosures, I-beam mounting kits, and outdoor enclosures; and products for improving security and minimizing the risk in deploying 802.11n wireless networks. It also provides Wi-Fi Array, a wireless networking device that integrates radios, high-gain directional antenna systems, multi-gigabit switches, controllers, firewalls, threat sensors, and embedded spectrum analyzers. In addition, the company offers power over gigabit Ethernet (PoGE) products; and a Management System, which offers a platform for the central management of a Wi-Fi Array network. It serves general enterprise, higher education, K-12 education, conference centers, hospitality, and manufacturing markets. The company was founded in 2004 and is headquartered in Thousand Oaks, California.

Follica, Inc.

Series B in 2008
Follica, Inc. develops a treatment system for hair loss in adult humans. It offers an in-office treatment proprietary device that disrupts the skin and creates new hair follicles; and at-home treatment system that delivers compounds directly to the scalp for a daily routine. Follica, Inc. was incorporated in 2005 and is based in Boston, Massachusetts. Follica, Inc. operates as a subsidiary of PureTech Health plc.

Totango Ltd.

Series B in 2014
Totango, Inc. develops an enterprise grade customer success platform that allows users to connect their customers’ data, monitor health changes, and engage their customers. The company offers Customer Success Centre, a solution for customer engagement; Zoe, a solution for enterprise impact; and DNA-CX, a solution for multidimensional customer context in real-time. Its solutions include voice of the customer, customer onboarding, customer adoption, customer renewal, and customer escalation. The company was founded in 2010 and is based in Redwood City, California. Totango, Inc. operates as a subsidiary of Totango Ltd.

Marketo

Series E in 2010
Marketing automation software

Glaukos Corporation

Series D in 2008
Glaukos Corporation is an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures designed to transform the treatment of glaucoma, one of the world’s leading causes of blindness. They have pioneered Micro-Invasive Glaucoma Surgery, or MIGS, in order to revolutionize the traditional glaucoma treatment and management paradigm. They launched the iStent®, their first MIGS device, in the United States in 2012. They are leveraging their platform technology to build a comprehensive and proprietary portfolio of injectable micro-scale therapies designed to address the complete range of glaucoma disease states and progression. They believe the iStent® is the smallest medical device ever approved by the Food and Drug Administration, or FDA, measuring 1.0 mm long and 0.33 mm wide. In June 2015, they completed an initial public offering and their shares are now traded on the New York Stock Exchange under the ticker symbol “GKOS”. The company was founded in 1998 and is based in San Clemente, California.

ReVision Optics

Series C in 2006
ReVision Optics, Inc. designs, manufactures, and delivers implantable products for the treatment of presbyopia. It offers PRESBYLENS Corneal Inlay, a refractive surgery solution to correct vision lost by the natural aging process called presbyopia. The company serves the ophthalmology professionals. ReVision Optics, Inc. was formerly known as IntraLens Vision, Inc. and changed its name to ReVision Optics, Inc. in 2005. The company was founded in 1996 and is based in Lake Forest, California.
The mission of Integrated Diagnostics is to leverage powerful emerging technologies in the development of diagnostic products that enable physicians and patients to manage complex and important diseases such as cancer, diabetes and Alzheimer's through blood tests that can monitor tens to hundreds of disease markers simultaneously. The company plans to develop a pipeline of game-changing diagnostic products that enable the diagnosis and prognosis of a variety of diseases. The company is based on the concept of a systems view of disease where pathophysiology arises from disease-perturbed networks of proteins, genes and other molecules.

Voyence

Venture Round in 2004
Voyence provides configuration and change management solutions that automate critical change, compliance, and activation processes. The company offers VoyenceControl NG solution, which manages various devices in a heterogeneous infrastructure; automates configuration management lifecycle, including design, change, and compliance; and collects data in its repository, including configuration, asset/hardware, and change and audit information. It offers compliance/security, change/configuration, and extending network management solutions. The company's customers include financial, healthcare, education, government, manufacturing, services, technology, and transportation organizations. Voyence, Inc. was founded in 2000 as PowerUp Networks and it changed its name to Voyence, Inc. in 2003. The company is headquartered in Richardson, Texas.

LongBoard

Series B in 2001
LongBoard, Inc. provides software solutions to enable the telecommunications carriers and service providers to deliver converged multimedia services. Its products include MediaRoam that provides telecommunications carriers with the ability to deliver differentiated Initiation Protocol Multimedia Subsystem enabled multimedia services across fixed and mobile networks; LongBoard Multimedia Application Platform, which provides a carrier-class software infrastructure for integrating IP-based communications; and OnePhone, a personal mobility application that automatically and transparently switches calls between cellular and WiFi networks. LongBoard, Inc. was formerly known as Persona Software, Inc. and it changed its name to LongBoard, Inc. in February 2006. The company was founded in 1999 and is based in Santa Clara, California with sales offices in London, the United Kingdom and Tokyo, Japan.

DataRPM Corporation

Series A in 2014
DataRPM provides a Cognitive Data Science platform on the cloud or on-premises for enterprises to build data products for Predictive Analytics and Recommender Systems. Enterprises across the globe are using DataRPM to digitally transform their businesses in the core areas of Predictive Maintenance, Product Recommendations, Content Recommendations, Churn Predictions, and Conversion Predictions. DataRPM prides itself on delivering the fastest and scalable automated data science platform with a natural language question-answering interface which guarantees a return on investment for their customers and turns everyone in the organization into citizen data scientists.

Metro Optix

Series C in 2001
Metro-Optix develops hardware for telecommunications companies that want to transition from circuit-based services to cell- and packet-based services. The hardware essentially reduces the number of hardware boxes needed, such as routers, which the networks feed into.

eNeura Therapeutics

Series B in 2005
ENeura Therapeutics is a medical technology company developing transcranial magnetic stimulation devices for the treatment of migraines. It pioneers the use of portable, non-invasive Transcranial Magnetic Stimulation (TMS) devices for the treatment of migraine. Prescribed by physicians but designed for patient use, it is the first truly portable, convenient TMS product that will allow migraine patients to administer treatment as needed—at home, in the office, or on the go.

Bivio Networks

Venture Round in 2006
Founded in 2000, Bivio Networks is dedicated to providing leading networking products that enable government agencies and service providers to control, monitor, and secure critical network infrastructure. A leader in cyber intelligence, cyber security and network control solutions, Bivio has deployed its products in a wide range of solutions. Bivio’s global customer base includes leading intelligence agencies, military organizations and service providers. Bivio is privately-held and is headquartered in the San Francisco Bay Area with office locations worldwide. Specialties Cyber Security, Cyber Intelligence, Deep Packet Inspection (DPI) Networking Systems, Mass Metadata Extraction and Analysis, Data Retention System, Cyber Investigation, network probe

MacroGenics

Series D in 2008
MacroGenics, Inc., a biotechnology company, focuses on the development, manufacture, and commercialization of immunotherapeutics for autoimmune disorders, cancer, and infectious diseases. The company is developing immune-based products, including monoclonal antibodies; and vaccines to prevent infections in healthy individuals. The company's Fc engineering technology enables to improve antibody functions to eliminate cancer cells. It is also developing products around the Dual Activating ReTargeting technology. The company was founded in 2000 and is headquartered in Rockville, Maryland.

Pivot3

Series B in 2005
Global Hyper-Converged Infrastructure

CardioMind

Series C in 2007
CardioMind, Inc. Inc manufactures therapeutic devices for cardiovascular diseases. The company also offers stent delivery systems, which are designed for use in lesion applications, as well as for the treatment of coronary and peripheral artery diseases. In addition, it provides invasive endovascular medical devices for treating neurological and cardiovascular diseases. The company was founded in 2003 and is based in Sunnyvale, California.

Motiva

Series D in 2002
Motiva, Inc. is the technology leader for global enterprise incentive management (EIM) software and services, enabling companies to create and manage flexible, highly targeted incentive programs that drive top-line and bottom-line results across the extended enterprise. The Motiva software solution allows businesses to rapidly align performance with strategic objectives for sales, services, channels, customers and suppliers. Founded in 1996, Motiva is headquartered in Pleasanton, California.

Welltok

Series C in 2014
Welltok is a data-driven, enterprise SaaS company that delivers the healthcare industry’s leading consumer activation platform. Welltok’s solutions empower health plans, employers, providers, and public entities to connect consumers with personalized health improvement resources, making it easy and rewarding for consumers to complete actions that optimize their health and wellbeing. The company was founded in 2009 and headquartered in Denver, Colorado.

C3

Series D in 2016
C3 IoT is the leading AI and IoT software platform provider for digital transformation. C3 IoT delivers a comprehensive and proven platform as a service (PaaS) for rapidly developing, deploying, and operating large-scale AI, predictive analytics, and IoT applications at scale for any enterprise value chain in any industry. At the core of the C3 IoT offering is the revolutionary C3 Type System—an extensible, model-driven AI architecture that dramatically enhances data scientist and application developer productivity. C3 IoT also offers configurable, high-value SaaS products for predictive maintenance, fraud detection, sensor network health, supply chain optimization, energy management, and customer engagement.

Southampton Photonics

Series B in 2003
Southampton Photonics Ltd., a U.K. startup. The company, with origins at Southampton University's Optical Research Center (ORC), aims to establish itself in the design and manufacture of fiber-optic components for the dense wave-division multiplexing (DWDM) and optical telecommunications market using technology from the university.

Nanostim

Venture Round in 2012
Nanostim is an early-stage medical device company working to prevent more than 100,000 annual complications related to pacemakers. Nanostim has assembled a world-class team of experienced medical device engineers to help bring this exciting technology to the marketplace.

RHK

Series A in 2000
RHK is the leading industry market research and consulting firm specializing in the analysis of advanced technologies for the public telecommunications network. The company provides subscription services and custom consulting to technology vendors, service providers, component suppliers and the investment community.

C9 Inc.

Series A in 2005
C9 delivers predictive sales and marketing applications that increase revenue, generate more precise forecasts and mitigate pipeline risk. By combining data science with products that improve sales and marketing execution, C9 enables leading companies like Yahoo!, Pitney Bowes and Google to drive predictable growth. C9 is located in San Mateo and is backed by the Mayfield Fund, InterWest Partners and Leapfrog Ventures.

Carbylan Therapeutics

Series A in 2006
Carbylan Therapeutics was founded in 2004 with worldwide headquarters currently located in Palo Alto, California. They are a clinical-stage specialty pharmaceutical company focused on the development and commercialization of proprietary combination therapies. Our vision is to deliver best-in-class therapies to large growing markets where there is a clear unmet clinical need.

NovusEdge

Series B in 2006
NovusEdge Inc. provides physical security solutions that control access and monitor environments, and manage alerts to protect assets. It offers EdgeProtect, an integration software that integrates with existing technology investments, including asset protection devices, building automation systems, and IT network management consoles; and EdgeManager, which delivers various capabilities required for asset protection.

Marketo

Series A in 2006
Marketing automation software

Southampton Photonics

Series A in 2000
Southampton Photonics Ltd., a U.K. startup. The company, with origins at Southampton University's Optical Research Center (ORC), aims to establish itself in the design and manufacture of fiber-optic components for the dense wave-division multiplexing (DWDM) and optical telecommunications market using technology from the university.

Spredfast

Series C in 2013
Spredfast, Inc. provides a social relationship platform that allows enterprise brands and organizations to manage, monitor, and measure their social media programs in the United States and internationally. The company was formerly known as Social Agency, Inc. and changed its name to Spredfast, Inc. in January 2010. Spredfast, Inc. was founded in 2008 and is based in Austin, Texas with an additional office in London, United Kingdom. As of October 2, 2018, Spredfast, Inc. operates as a subsidiary of Lithium Technologies Inc.

BioMimetic Therapeutics

Series C in 2005
BioMimetic Therapeutics is a biotechnology company that develops products to help stimulate the body natural tissue regenerative process. The company's products and product candidates include Augment Injectable and Augment Rotator Cuff for several orthopedic and sports medicine indications comprising the treatment of foot and ankle fusions, the stimulation of wrist fracture healing, and the surgical treatment of rotator cuff tears, as well as Augment Tendinopathy Injection for injuries cause of tendon overuse. BioMimetic Therapeutics was founded on 1999 and is headquartered in Franklin, Tennessee.

C9 Inc.

Series C in 2010
C9 delivers predictive sales and marketing applications that increase revenue, generate more precise forecasts and mitigate pipeline risk. By combining data science with products that improve sales and marketing execution, C9 enables leading companies like Yahoo!, Pitney Bowes and Google to drive predictable growth. C9 is located in San Mateo and is backed by the Mayfield Fund, InterWest Partners and Leapfrog Ventures.
QuatRx Pharmaceuticals Company, a biopharmaceutical company, engages in discovering, licensing, developing, and commercializing compounds in the areas of endocrine, metabolic, and cardiovascular therapeutics. Its products include Osphena for the treatment for vaginal atrophy, a common problem associated with estrogen deficiency in post-menopausal women. QuatRx Pharmaceuticals Company was founded in 2000 and is based in Ann Arbor, Michigan.

Pivot3

Venture Round in 2012
Global Hyper-Converged Infrastructure

Kajeet

Series A in 2006
Kajeet, the industry leader for safe, mobile student Internet connectivity, is closing the Homework Gap in school districts across the country. Kajeet provides an affordable mobile broadband solution that connects low-income students to the resources needed to complete homework. The Kajeet SmartSpot® (a portable Wi-Fi hotspot), and the Kajeet SmartBus™ (school bus Wi-Fi) solutions combined with the innovative Sentinel® cloud portal, enables administrators and teachers to provide CIPA-compliant, customizable filtered Internet access that keeps students focused on school work and provides mobile Internet connectivity for education without worry of data abuse.

OPAL

Series A in 2014
Opal is a marketing collaboration platform for modern marketing teams. Working in Opal helps teams align on strategy, create campaigns with confidence, streamline the reviews process, improve the facilitation of content, and seamlessly integrate with a team’s preferred distribution method. The Opal Platform tears down silos, reduces complexity, and connects teams across the enterprise for winning results. It was founded in 2011 and is headquartered in Portland, Oregon.

Splice Machine, Inc.

Series B in 2017
Splice Machine is a data platform that offers offline, and batch analysis, and powers intelligent applications for operational workflows. Splice Machine is disrupting the $30 billion traditional database world with the open-source dual-engine RDBMS for mixed operational and analytical workloads, powered by Apache Hadoop and Apache Spark. The Splice Machine RDBMS executes operational workloads on Apache HBase® and analytical workloads on Apache Spark. Splice Machine makes it easy to develop and create modern, real-time, scalable applications, or to offload operational and analytical workloads from expensive Oracle, Teradata, and Netezza systems. Typical use cases are ETL, operational reporting, or real-time applications.
Applied Genetics Technologies Corporation (AGTC) is developing therapies designed to transform the lives of patients with severe diseases, offering hope to patients with unmet medical needs. With a highly specialized team of physicians and researchers, They use cutting-edge techniques to develop treatments for patients that have diseases caused by broken genes. They use gene therapy, which replaces those broken genes with normal functional genes, allowing a patient’s own body to produce proteins to treat their illness. A single injection provides long-lasting treatment, leading to a better quality of life for patients worldwide.

Spredfast

Series F in 2016
Spredfast, Inc. provides a social relationship platform that allows enterprise brands and organizations to manage, monitor, and measure their social media programs in the United States and internationally. The company was formerly known as Social Agency, Inc. and changed its name to Spredfast, Inc. in January 2010. Spredfast, Inc. was founded in 2008 and is based in Austin, Texas with an additional office in London, United Kingdom. As of October 2, 2018, Spredfast, Inc. operates as a subsidiary of Lithium Technologies Inc.

Benvenue Medical

Series E in 2014
Benvenue Medical, Inc. is developing innovative, minimally invasive surgical solutions to treat spinal disorders. The company is privately held and funded by CRG Partners.

LensX Lasers

Series B in 2009
LensX Lasers is a maker of surgical lasers used to repair cataracts.

Avedro

Series F in 2018
Medical device and pharmaceutical company advancing the science and technology of corneal cross-linking

Vendavo, Inc.

Series D in 2004
Vendavo is the provider of price management and optimization software for business-to-business companies worldwide. The Vendavo Enterprise Pricing Suite solves pricing problems by giving businesses true enterprise-wide control of their entire pricing process. Vendavo combines pricing science, pricing best practices, and enterprise-class software to drive improvements in average prices at every stage of the pricing process, from segmentation to deal close. Added up, these improvements deliver significant increases in profits from 10% to 30%. Vendavo is the enterprise price management and optimization solution of choice for some of the worlds biggest companies in chemicals, high-tech, industrial manufacturing, consumer products, mill products and distribution. SAP, the worlds leading provider of business software, with more than 33,200 customers in more than 120 countries, sources its price and margin management solution from Vendavo. It is sold by SAP worldwide under the name SAP Price and Margin Management.

Brand.net

Series C in 2010
Brand.net is an online advertising network focused exclusively on brand advertising. Their technology is designed to allow Brand advertisers and agencies to reach the right target in the right context, efficiently and measurably.

Staccato Communications

Venture Round in 2007
Staccato Communications, Inc. offers ultra wideband wireless enabled devices for the wireless USB, Bluetooth, and Internet protocol connectivity to the personal computing, consumer electronics, and mobile phone industries. Its products include single-chip integrated circuits, device adapter and device module design kits, reference design kits, wireless USB development kits, and streaming services development kits. The company also provides Ripcord Software, which provides a software stack for variety of ultra wide band applications, as well as includes installers, firmware, middleware, drivers, customization tools, and firmware upgrade tools. Staccato Communications’ products are used in various applications, such as printers, camera, mass storage devices, portable media players, wireless docking, wireless projectors, Web cameras, wireless HDTV, wireless speakers, set top boxes, wireless displays, purchasing content, sharing content, and personal servers. Staccato Communications, Inc. was formerly known as Discrete Time Communications, Inc. The company was founded in 2002 and is based in San Diego, California.

Grokker Inc.

Series B in 2016
Grokker takes the work out of workplace wellness with an easy-to-implement, holistic, and cost-effective program. With over 3,700 exercise, mindfulness, nutrition, finance, and sleep videos from 5 to 50 minutes, more than 130 master experts to choose from, and a supportive community to connect employees across locations, Grokker’s patented program delivers results.

Cardiac Dimensions

Series B in 2002
Cardiac Dimensions, Inc., a medical device company, engages in the development of minimally invasive treatment modalities to address heart failure and related cardiovascular conditions. The company develops Carillon Mitral Contour System, a permanent implant for the treatment of functional mitral regurgitation. The company was incorporated in 2000 and is based in Kirkland, Washington with additional operations in Sydney, Australia and Offenbach, Germany.

Solace Pharmaceuticals

Series A in 2007
Solace Pharmaceuticals, a Boston based drug company focused on therapeutics for chronic pain.

KAI Pharmaceuticals

Series B in 2006
KAI Pharmaceuticals is a drug discovery and development company with multiple, novel clinical-stage programs in the areas of cardiovascular disease, kidney disease and pain. KAI lead product candidate, KAI-9803, is currently in a Phase 2b study (PROTECTION AMI) designed to assess the effect of KAI-9803 on reducing myocardial injury in heart attack patients. KAI second core program, KAI-4169 for the treatment of secondary hyperparathyroidism (SHPT) in kidney disease patients, is expected to enter human clinical trials in 2010. KAI also has an ongoing pain program, KAI-1678, which is currently in Phase 2a testing.

Bivio Networks

Venture Round in 2005
Founded in 2000, Bivio Networks is dedicated to providing leading networking products that enable government agencies and service providers to control, monitor, and secure critical network infrastructure. A leader in cyber intelligence, cyber security and network control solutions, Bivio has deployed its products in a wide range of solutions. Bivio’s global customer base includes leading intelligence agencies, military organizations and service providers. Bivio is privately-held and is headquartered in the San Francisco Bay Area with office locations worldwide. Specialties Cyber Security, Cyber Intelligence, Deep Packet Inspection (DPI) Networking Systems, Mass Metadata Extraction and Analysis, Data Retention System, Cyber Investigation, network probe

Joyus

Series C in 2015
Joyus is a startup that's helping shoppers discover goods via short-form videos. Welcome to Joyus, a brand new online shopping experience to help you discover and buy the things you'll love. Our purpose at Joyus is to help delight and transform your shopping experience by harnessing the power of video. Each week our amazing curators share their special apparel, beauty and lifestyle finds with you and then show you how to make them work for you. Each item is available for sale for a limited time through our exclusive video sales platform, making it easy for you to buy the things you love. You can also easily share these videos with your friends on Facebook and Twitter with just a simple click. Whether it's uncovering the latest trends, bringing our favorite brands with you, or solving a dilemma - all our video sales share one thing in common. We believe that sharing our authentic passion and finds with you is the key to creating a truly Joyus shopping experience online.

Pelican Imaging

Series A in 2009
Pelican Imaging Corporation is a venture-backed software start-up in the business of commercializing computational cameras for the smartphone market. The company is developing a new camera technology that directly addresses the challenges posed by conventional camera design and small pixels. Investors include Globespan Capital Partners, Granite Ventures, InterWest Partners, and IQT.

Invuity

Series E in 2014
Invuity, Inc. develops visualization products for the less invasive surgical field applications. It offers BriteField Port System that provides illumination and visualization during minimally invasive procedures; and BriteField McCulloch retractor, which allows physicians to achieve visualization during surgery while using traditional techniques. Invuity, Inc. was formerly known as Spotlight Surgical Inc. The company was founded in 2004 and is headquartered in San Francisco, California.

Potenza Therapeutics

Venture Round in 2016
Potenza Therapeutics, Inc. is a preclinical-stage biotechnology company focused on building a portfolio of oncology programs that utilize the body’s own immune system to seek out, recognize and destroy tumors through a diversity of mechanisms that influence tumor immunity. It was founded in 2014 and headquartered in Cambridge, Massachusetts.

Empowered Careers

Series A in 2011
As a pioneer in mobile education technology, Empowered Careers works tirelessly in developing and implementing innovative mobile technology products to accommodate evolving academic trends and student needs. Our technology solutions are designed for anytime, anywhere learning, while maintaining the highest quality content that prestigious universities and organizations demand.

Pelican Imaging

Series B in 2010
Pelican Imaging Corporation is a venture-backed software start-up in the business of commercializing computational cameras for the smartphone market. The company is developing a new camera technology that directly addresses the challenges posed by conventional camera design and small pixels. Investors include Globespan Capital Partners, Granite Ventures, InterWest Partners, and IQT.

Cebix

Series B in 2012
Cebix is focused on the development of chronic replacement therapy based on human proinsulin C-peptide for the treatment of type 1 diabetic neuropathy. The role of C-peptide will also be explored in type 1 diabetic nephropathy and retinopathy.

AppMesh

Series A in 2013
AppMesh is building the next generation business platform for mobile devices. Founded by salesforce.com veterans, we believe that in the post-PC era business applications need to be personal, seamless, and intuitive.

Cardiac Dimensions

Series C in 2004
Cardiac Dimensions, Inc., a medical device company, engages in the development of minimally invasive treatment modalities to address heart failure and related cardiovascular conditions. The company develops Carillon Mitral Contour System, a permanent implant for the treatment of functional mitral regurgitation. The company was incorporated in 2000 and is based in Kirkland, Washington with additional operations in Sydney, Australia and Offenbach, Germany.

Fluidigm

Series D in 2004
Fluidigm Corporation develops and distributes systems based on the properties of integrated fluidic circuits to control precisely fluids on a nano volume scale. The company's product line includes the TOPAZ system, which is used for protein crystallization; and the BioMark system, which is used for genetic analysis. Fluidigm Corporation was founded as Mycometrix Corporation in 1999 and was renamed as Fluidigm Corporation in 2001. The company is based in San Francisco, California.

Tapjoy

Series C in 2011
Tapjoy’s Maximum Impact Platform™ provides mobile engagement and monetization services for leading advertisers and app developers. Advertisers rely on Tapjoy’s diverse suite of rewarded Interplay™ ads including video and rich media to impact performance. Developers utilize our technology and mobile expertise to acquire and monetize users. The Tapjoy SDK is currently embedded in over 15,000 mobile apps, reaching 520 million monthly active users. A 2016 comScore™ study confirmed Tapjoy Interplay® ads deliver an unprecedented 3x lift across all brand metrics. The company works with Fortune 500 brands and the Top 200 grossing app developers. Founded in 2007, Tapjoy is a global organization with more than a dozen offices worldwide and is headquartered in San Francisco.

Chiaro Networks

Series D in 2002
Chiaro Networks, Inc. engages in the design, manufacture, and delivery of Internet protocol/multi protocol label switching in the United States.

Tapjoy

Series B in 2009
Tapjoy’s Maximum Impact Platform™ provides mobile engagement and monetization services for leading advertisers and app developers. Advertisers rely on Tapjoy’s diverse suite of rewarded Interplay™ ads including video and rich media to impact performance. Developers utilize our technology and mobile expertise to acquire and monetize users. The Tapjoy SDK is currently embedded in over 15,000 mobile apps, reaching 520 million monthly active users. A 2016 comScore™ study confirmed Tapjoy Interplay® ads deliver an unprecedented 3x lift across all brand metrics. The company works with Fortune 500 brands and the Top 200 grossing app developers. Founded in 2007, Tapjoy is a global organization with more than a dozen offices worldwide and is headquartered in San Francisco.

Paracor Medical

Series C in 2004
Paracor Medical is an innovative medical device company focused on providing unique, technology-driven solutions for the treatment of heart failure. Founded in 1999, Paracor was established to pursue new and innovative ways to treat heart failure (HF) that would not require the patient to undergo open chest surgery. Paracor engineers recognized that a mechanical approach to reducing the workload of a failing, diseased heart muscle could be a new and effective solution.

Gynesonics

Series B in 2007
Gynesonics, Inc. designs and develops minimally invasive solutions for symptomatic uterine fibroids in women. The company offers Sonography-Guided Transcervical Fibroid Ablation (Sonata) System(The Sonata System) for the transcervical treatment of symptomatic uterine fibroids under intrauterine sonography guidance serving customers in the European Union. Gynesonics, Inc. was founded in 2005 and is based in Redwood City, California with an additional location in Beuningen, the Netherlands.

Intarcia Therapeutics

Series D in 2003
Intarcia Therapeutics is a biopharmaceutical company that develops therapies for diseases that require long-term chronic treatment. It offers DUROS, a drug delivery platform that stabilizes and delivers therapeutic proteins and peptides. Intarcia Therapeutics' products include OMEGA DUROS, an interferon delivery device for treating Hepatitis C and ITCA 650, a delivery device that provides type 2 diabetes patients with long-term steady state dosing of an incretin mimetic therapy. Additionally, it develops programs for treating obesity. David Franklin, James M. Ahlers, and Thomas Alessi founded BioMedicines in 1997 that became Intarcia Therapeutics in September 2004. Its headquarters is in Hayward in California with an additional office in Mountain View in California.

Varolii

Series D in 2011
Varolii is the market and technology leader in proactive outbound communications. Its on-demand communication software and services help organizations more effectively reach and interact with their customers and employees, getting the best result from every interaction. By automating the processes required for personalized communications such as flight cancellation notices, fraud detection alerts and prescription pick-up reminders, Varolii helps its clients reduce operational costs, increase contact center efficiency, and get more out of their existing IT investments. More than 380 companies, including many of the largest U.S. banks, airlines, wireless carriers, utilities, and healthcare organizations trust Varolii to send 4 million communications every business day. Varolii is headquartered in Seattle with offices in the Boston and Denver metropolitan areas. Varolii was acquired by Nuance Communications (NASDAQ: NUAN) in October 2013 for an undisclosed price.

Aryaka Networks

Series C in 2015
[Aryaka](http://www.aryaka.com)'s Global SD-WAN provides optimized, software-defined network connectivity and application acceleration to globally distributed enterprises. Aryaka’s services have over 10 million users across more than 4,000 sites. Leading brands such as Skullcandy, Air China, Freescale Semiconductor, and ThoughtWorks, as well as partners such as Microsoft Azure, AWS, Intelisys, and SK Broadband, have all chosen Aryaka for their enterprise-grade networking needs.

Vizionware

Series B in 2007
VizionWare offers audio and video digital interconnect technology solutions for consumer and commercial A/V applications. It offers high definition multimedia interface (HDMI) digital interconnects, fiber optic HDMI interconnects, digital visual interface (DVI) digital interconnects, HDMI-to-DVI digital interconnects, switcher and digital audio synchronizers, integrator-friendly accessory products, HDMI and DVI swivel adapters, HDMI connector locking mounts, and heavy duty cable pull through socks. The company serves home theater, commercial, original equipment manufacturer, and consumer markets. VizionWare was founded in 2004 and is based in Austin, Texas.

Nuventix

Series A in 2008
Nuventix is an active thermal management solutions company located in Austin, Texas. The Nuventix-developed SynJet® module is a newly patented synthetic jet cooling technology that utilizes turbulent pulses of air generated from an electromagnetic actuator. Based on early success with computer cooling, Nuventix's innovative approach to LED cooling is propelling that market forward two years ahead of analyst estimates - truly affecting the industry and allowing general illumination designs to harvest the efficiencies of the LED.

Follica, Inc.

Series A in 2008
Follica, Inc. develops a treatment system for hair loss in adult humans. It offers an in-office treatment proprietary device that disrupts the skin and creates new hair follicles; and at-home treatment system that delivers compounds directly to the scalp for a daily routine. Follica, Inc. was incorporated in 2005 and is based in Boston, Massachusetts. Follica, Inc. operates as a subsidiary of PureTech Health plc.

Bigstep

Seed Round in 2016
Bigstep.com is a cloud provider dedicated to making professional analytics solutions accessible to companies of all sizes. It enables businesses, large and small, to get started with a production-ready big data environment in just a few clicks, all in the Full Metal Cloud, purpose built for big data. Bigstep.com was founded in 2013 by Lucas Roh, serial entrepreneur, and founder of Hostway Corporation and Affinity Global. It is headquartered in London and operates infrastructure in the U.K. and Germany.

ChipData

Series A in 2000
ChipData a business-to-business design chain management company for electronic design engineers.

Lombardi Software

Series D in 2007
A suite of business process management software and services in the united states

Elitra Pharmaceuticals

Venture Round in 2000
Elitra Pharmaceuticals in San Diego, CA is a private company categorized under Pharmaceutical Preparations. It was established in 1997 and incorporated in California.

Aria Systems, Inc.

Series D in 2013
Proven by the world's most demanding enterprises, including AAA NCNU, Constant Contact, Falck, Hootsuite, Pitney Bowes, Audi, Adobe, Telekom Denmark, Philips, Roku, and VMware, Aria helps enterprises grow their recurring revenue businesses. Aria helps clients take advantage of each customer-driven event − known as revenue moments − with agile billing, active customer engagement, and the rapid development of new products and services. With Aria's end-to-end active monetization platform, global brands can get to market faster with a wider variety of products and services, while maximizing customer satisfaction, retention, and lifetime value.

The RealReal, Inc.

Series G in 2018
The RealReal, Inc. operates an online marketplace for consigned luxury goods. It offers various resale product categories, including women’s, men’s, kids’, jewelry, and watches, as well as home and art products. The company was founded in 2011 and is headquartered in San Francisco, California.

Applied Science Fiction

Venture Round in 1999
Applied Science Fiction Developer of technologies with commercial applications for digital and photographic industries. The Company's products include Digital Film Processing Technology and ICE3, which eliminates scratches on photographic film or slides, restores color fidelity and improves on a photograph's overall appearance.

Right90

Series B in 2007
Right90 is a sales and revenue forecasting software, designed to increase accountability in a company's sales department by actively compiling and analyzing data from different departments within the sales and management branches. Right90, Inc. was founded in 2003 and is headquartered in Foster City, California.

The RealReal, Inc.

Series E in 2016
The RealReal, Inc. operates an online marketplace for consigned luxury goods. It offers various resale product categories, including women’s, men’s, kids’, jewelry, and watches, as well as home and art products. The company was founded in 2011 and is headquartered in San Francisco, California.

Alfalight

Series B in 2000
Alfalight designs and manufactures high-power diode lasers for the industrial, defense, and telecommunications markets. Alfalight's innovative technology is based on advanced aluminum-free active region (ALFA) laser structures, enabling the manufacture of laser diodes with exceptionally high reliability and industry-leading efficiency.

Joyus

Series B in 2013
Joyus is a startup that's helping shoppers discover goods via short-form videos. Welcome to Joyus, a brand new online shopping experience to help you discover and buy the things you'll love. Our purpose at Joyus is to help delight and transform your shopping experience by harnessing the power of video. Each week our amazing curators share their special apparel, beauty and lifestyle finds with you and then show you how to make them work for you. Each item is available for sale for a limited time through our exclusive video sales platform, making it easy for you to buy the things you love. You can also easily share these videos with your friends on Facebook and Twitter with just a simple click. Whether it's uncovering the latest trends, bringing our favorite brands with you, or solving a dilemma - all our video sales share one thing in common. We believe that sharing our authentic passion and finds with you is the key to creating a truly Joyus shopping experience online.

Grokker Inc.

Series A in 2014
Grokker takes the work out of workplace wellness with an easy-to-implement, holistic, and cost-effective program. With over 3,700 exercise, mindfulness, nutrition, finance, and sleep videos from 5 to 50 minutes, more than 130 master experts to choose from, and a supportive community to connect employees across locations, Grokker’s patented program delivers results.

Sequel Pharmaceuticals

Series A in 2007
Sequel Pharmaceuticals, Inc., a pharmaceutical company, develops and commercializes novel and clinical-stage drug candidates for patients with cardiovascular disease. The company was founded in 2007 and is based in San Diego, California.

Restoration Robotics

Series C in 2011
Restoration Robotics is a privately held medical device company, is dedicated to revolutionizing the field of hair transplantation by developing and commercializing a state-of-the-art image-guided system (ARTAS™ System) that enables follicular unit extraction.

Radiant Medical

Venture Round in 2005
Radiant Medical provides medical devices intended for endovascular temperature therapy. They are a private medical device company pioneering the development of endovascular therapeutic cooling for the treatment of heart, brain, and kidney disorders. It was founded in 1999 and is headquartered in Redwood City, California.

Vendavo, Inc.

Series E in 2005
Vendavo is the provider of price management and optimization software for business-to-business companies worldwide. The Vendavo Enterprise Pricing Suite solves pricing problems by giving businesses true enterprise-wide control of their entire pricing process. Vendavo combines pricing science, pricing best practices, and enterprise-class software to drive improvements in average prices at every stage of the pricing process, from segmentation to deal close. Added up, these improvements deliver significant increases in profits from 10% to 30%. Vendavo is the enterprise price management and optimization solution of choice for some of the worlds biggest companies in chemicals, high-tech, industrial manufacturing, consumer products, mill products and distribution. SAP, the worlds leading provider of business software, with more than 33,200 customers in more than 120 countries, sources its price and margin management solution from Vendavo. It is sold by SAP worldwide under the name SAP Price and Margin Management.

Archus Orthopedics

Series B in 2003
Archus Orthopedics is focused on the development of implants to treat a variety of spine disorders that result from degenerative changes in the facet joints. Archus Orthopedics offers Total Facet Arthroplasty System, a spinal implant that is designed for patients suffering from lumbar spinal stenosis. Archus Orthopedics was acquired by Facet Solutions in November 2009. Archus Orthopedics was founded in 2001 and is based in Redmond, Washington.
INVIDI Technologies Corporation provides software applications that track targeted advertising. It offers Advatar, a digital set-top box application that delivers addressable targeted advertising and marketing messages to individual viewers. It facilitates the sales of digital products, digital tiers, and digital services, such as VOD, PVR, and pay-per-view events; Internet, voice, and wireless services; and triple play offers. Advatar serves multi-channel video programming distributors, marketers, advertisers, and media buyers and sellers. The company also provides INVIDI Advertising Decision System, an addressable television advertising technology for managing advertising decisions and selections for household delivery in the evolving business of television advertising. INVIDI Technologies Corporation was founded in 2000 and is headquartered in Princeton, New Jersey.

Scale Eight

Series C in 2001
Scale Eight is an internet company. It offers virtually limitless storage capacity, allowing companies to grow their online offerings. Scale Eight delivers file storage solutions technology through its global storage service and in a family of network-attached storage products. Scale Eight was founded by Josh Coates and is located in San Francisco, California.

Brecis Communications

Series A in 2000
BRECIS Communications, a communications company focused on leading-edge, broadband multi-service network processor architectures.

Spiration

Series E in 2004
Spiration, Inc., doing business as Olympus Respiratory America, develops medical devices for the treatment of air leaks and lung diseases. The company was founded in 1999 and is based in Redmond, Washington. As of 2010, Spiration, Inc. operates as a subsidiary of Olympus America Inc.